Home
  >  
Section 36

EurekaMag Full Text Articles Chapter 35,493



References:

Van Houtte, M.; Lecocq, P.; Mckenna, P.; Bacheler, L. 2003: Phenotypic resistance and prevalence of specific nucleoside analog mutation combinations in reverse transcriptase in a dataset of recent HIV-1 clinical isolates. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 43: 322
Kohlhepp, S.J.; Grunkemeier, G.; Leggett, J.E.; Dworkin, R.J.; Slaughter, S.E.; Gilbert, D.N. 2000: Phenotypic resistance of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae after single and multiple in vitro exposures to ciprofloxacin , gatifloxacin , levofloxacin , moxifloxacin and trovafloxacin. Clinical Infectious Diseases 31(1): 230
Fincher, E.F.; Russell, A.J.; Marinkovich, M.P.ter 2000: Phenotypic reversion of alpha3-deficient human keratinocytes and functional studies of laminin 5. Molecular Biology of the Cell 11(Suppl): 391a-392a
Lipkin, G.; Rosenberg, M.; Brooks, P. 2003: Phenotypic reversion of melanoma in vitro suppresses metastasis in vivo. Journal of Investigative Dermatology 121(1): 1191
Keane, F.M.; Mcgrath, J.A.; Eady, R.A.J.; Pommeret, O.; Ortonne, J.P.; Meneguzzi, G.; Vailly, J. 2000: Phenotypic reversion of non-Herlitz junctional epidermolysis bullosa keratinocytes. British Journal of Dermatology 142(3): 604
Kurian, K.M.; Van Der Kammen, R.A.; Collard, J.G.; Wyllie, A.H.; Watson, C.J. 1999: Phenotypic reversion of transformed mammary epithelial cells with Tiam1. Journal of Pathology 187(Suppl): 4A
Stauber, R.E.; Hegenbarth, K.S.; Tiran, A.; Hoefler, G.; Zatloukal, K.; Stenzel, H.C. 2000: Phenotypic screening for hemochromatosis in 4000 Austrian military recruits. Hepatology 32(4 Pt 2): 489A
Wise, J.G.; Fromknecht, K. 1999: Phenotypic selection for new binding specificities from mutational/combinatorial libraries of a DNA binding protein. FASEB Journal 13(7): A1372
Vanier, C.H.; Thompson, D.B. 2001: Phenotypic selection in a disturbance-related novel environment. Ecological Society of America Annual Meeting Abstracts 86: 225
Miles, D.B. 2001: Phenotypic selection on body size and sprint performance in the tree lizard Urosaurus ornatus. Ecological Society of America Annual Meeting Abstracts 86: 158-159
Yasukawa, K.; Sawamura, D.; Mcmillan, J.; Shimizu, H. 2001: Phenotypic severity of epidermolysis bullosa simplex caused by a dominant missense mutation in the keratin 5 is exacerbated when combined with a silent missense mutation in another allele. Journal of Investigative Dermatology 117(2): 516
Schuffenhauer, S.; Albert, A.; Chahrokh Zadeh, S.; Kress, W.; Seidel, H.; Rost, I.; Buiting, K.; Meitinger, T. 2000: Phenotypic spectrum in five patients with an Angelman syndrome typical methylation pattern due to an imprinting defect. European Journal of Human Genetics 8(Suppl 1): 78
Soll, D.R. 2002: Phenotypic switching. Calderone, Richard A Author Candida and candidiasis Candida and candidiasis 123-142
Fries, B.C.; Serfass, E.; Casadevall, A. 2000: Phenotypic switching in Cryptococcus neoformans strain RC-2, a 24067 variant occurs in vivo and is associated with secretion of a high molecular weight glucuronoxylomannan. Abstracts of the General Meeting of the American Society for Microbiology 100: 324
Thakur, Y.P.; Singh, P.K.; Singh, B.P. 2000: Phenotypic time trend for milk yield and production efficiency traits in Jersey crossbreds. Indian Veterinary Medical Journal 24(2): 147-148
Bataller, R.; Gines, P.; Gasull, X.; Gorbig, N.; Garcia Ramallo, E.; Nicolas, J.M.; Gual, A.; Arroyo, V.; Rodes, J. 1999: Phenotypic transformation of hepatic stellate cells into myofibroblasts results in the expression of voltage-operated calcium channels. Journal of Hepatology 30(Suppl 1): 82
Yoo, K.H.; Choe, J.H.; Kim, K.B.; Hong, Y.S.; Lee, J.W.; Kim, S.K. 1999: Phenotypic transformation of tubular epithelial cells and fibroblasts following unilateral ureteral obstruction or angiotensin II infusion in the rat. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 566A
Dunkle, L.D.; Lipps, P.E. 2001: Phenotypic variability in Cercospora zeae-maydis. Phytopathology 91(6 Suppl): S24
Andermann, E.; Badhwar, A.; Seni, M.H.; Pandolfo, M.; Andermann, F. 2003: Phenotypic variability in Friedreich ataxia Spastic paraplegia in the absence of point mutations in the FRDA gene. American Journal of Human Genetics 73(5): 555
Guay-Woodford, L.M. 1999: Phenotypic variability in PKD1: the family as a starting point. Kidney International 56(1): 344-346
Somaschini, M.; Cavazza, A.; Montrasio, C.; Nogee, L.; Carrera, P. 2004: Phenotypic variability in a kindred with chronic pulmonary diseases associated with the I73T SP-C gene mutation. Biology of the Neonate 85(4): 339-340
Dickinson, J.L.; Craig, J.E.; Sale, M.; Nicholls, S.; Love, J.; Hanson, I.; Matthews, S.J.; Mackey, D.A. 1999: Phenotypic variability in a large aniridia pedigree with a novel PAX6 1410delC mutation. American Journal of Human Genetics 65(4): A292
Forlino, A.; Marini, J.C. 1999: Phenotypic variability in a murine model for the dominant negative disorder Osteogenesis Imperfecta. American Journal of Human Genetics 65(4): A46
Jansen, A.C.M.; van Wissen, S.; Defesche, J.C.; Kastelein, J.J.P. 2002: Phenotypic variability in familial hypercholesterolaemia: an update. Current Opinion in Lipidology 13(2): 165-171
Frenking, G.S.; Niehueser, J.; Stieb, N.; Kampmann, C.; Haney, D.; Mueller Forell, W.; Vetter, T.; Beck, M. 2003: Phenotypic variability in mucopolysaccharidosis type II Results of a clinical study in 20 patients. Acta Paediatrica 92(Suppl 443): 124
Parini, R.; Menni, F.; Fesslova, V.; Gioventu, M.; Ravaglia, R.; Brambillasca, F.; Bertagnoglio, B.; Hasholt, L. 2001: Phenotypic variability in the same family with Fabry disease. Journal of Inherited Metabolic Disease 24(Suppl 2): 151
Kanaan Atallah, Z.; Johnson, D.A. 2001: Phenotypic variability of Sclerotinia sclerotiorum isolates in potato fields in the Columbia Basin of Washington. Phytopathology 91(6 Suppl): S46
A.A.eel, A.I.; Rashed, M.S.; Ijist, L.; Ruiter, J.P.N.; Wanders, R.J.A. 2002: Phenotypic variability of carnitine palmityl transferase I deficiency with novel molecular defect in Saudi Arabia. American Journal of Human Genetics 71(4 Suppl): 412
Stiller, F. 1999: Phenotypic variability, deformations and post-traumatic reactions of the stem of Encrinus cf liliiformis LAMARCK from the Middle Triassic of Qingyan, south-western China. Paläontologische Zeitschrift 73(3-4): 303-318
Alpermann,T.J.; Tillmann,U.; Beszteri,B.; Cembella,A.D.; John,U. 2010: Phenotypic variation and genotypic diversity in a planktonic population of the toxigenic marine dinoflagellate Alexandrium tamarense. Journal Of Phycology: 1, 18-32
Engle, E.C.; Lee, B.A.; Sener, C.; Turgut, B.; Akarsu, A.N.; Khamis, A.R.; Mousawi, A.; Traboulsi, E.I. 1999: Phenotypic variation at the chromosome 12 CFEOM1 locus. American Journal of Human Genetics 65(4): A248
Kohlmann, W.K.; Ward, P.A.; Lynch, P.M.; Su, L.K. 2001: Phenotypic variation between two probands with FAP due to large deletions in exon 15 of the APC gene. American Journal of Human Genetics 69(4 Suppl): 253
Paskaleva, I.; Horvath, A.; Kirov, S.; Georgiev, B.; Ganev, V. 1999: Phenotypic variation in APOB3500 heterozygotes from a Bulgarian kindred with familial defective apolipoprotein B-100. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S144
Neiswanger, K.; Petiprin, S.S.; Bardi, K.M.; Ford, M.D.; Sauder, A.S.; Giles, R.F.; Weinberg, S.M.; Carter, E.S.; Cooper, M.E.; Marazita, M.L. 2001: Phenotypic variation in individuals with or without cleft palate and their unaffected family members. American Journal of Human Genetics 69(4 Suppl): 305
Cape, C.; Zaidman, G.; Bhatia, S.; Kaufman, A.; Beck, A.; Lambert, S. 2001: Phenotypic variation in ophthalmic manifestations of MIDAS syndrome associated with an Xp223 deletion. IOVS Investigative Ophthalmology and Visual Science 42(4): S114
Marcus, P.I.; Sekellick, M.J.; Ball, L.A.; Wertz, G.W. 1999: Phenotypic variation in the interferon-inducing capacity of vesicular stomatitis virus with rearranged genomes. Journal of Interferon and Cytokine Research 19(Suppl 1): S101
Ichihara, S.; Yamada, Y.; Ishihara, H.; Yokota, M. 1999: Phenotypic variation of familial hypertrophic cardiomyopathy caused by Phe110fwdarwIIe mutation in the cardiac troponin T. Circulation 100(18): I816-I817
Hughes, T.J.; Chen, W.; Grau, C.R.; Kurtzweil, N.C. 2000: Phenotypic variation within and among genotypically different isolates of Phialophora gregata. Phytopathology 90(6 Suppl): S37
Hauw, J.J.; Sazdovitch, V.; Laplanche, J.L.; Kopp, N.; Privat, N.; Delasnerie Laupretre, N.; Brandel, J.P.; Deslys, J.P.; Dormont, D.; Alperovitch, A. 1999: Phenotypic variations and prion protein genotype in sporadic Creutzfeldt-Jakob disease A neuropathological study. Neurology 52(6 Suppl 2): A418
King, A.; Rossor, M.; Doey, L.; Collinge, J.; Lantos, P. 2000: Phenotypic variations in a familial prion disease characterised by a 144 base pair insertion in the prion protein gene. Brain Pathology 10(4): 669
Vos, J.A.; Coad, J.E.; Brissette, M.D.; Myers, J.B. 2001: Phenotypic variations in the mucosal lymphoid tissue of celiac disease. FASEB Journal 15(4): A594
Sommardahl, C.S.; Cottrell, M.B.; Woychik, R.P.; Wilkinson, J.E.by 1999: Phenotypic variations of the orpk mouse model of polycystic kidney disease on the C3H genetic background. FASEB Journal 13(4 Part 1): A521
Porter, F.D.; Zhu, P.; Kratz, L.; Krakowiak, P.A.; Battaile, K.; Steiner, R.D.; Stewart, R.R.; Kelley, R.I.; Nwokoro, N.A.; Wassif, C.A. 2000: Phenotypic, biochemical, and neurophysiological characterization of a SLOS mouse model. American Journal of Human Genetics 67(4 Suppl 2): 280
Porter, F.D.; Zhu, P.; Stewart, R.R.; Wassif, C.A. 2001: Phenotypic, biochemical, and neurophysiological characterization of a Smith-Lemli-Opitz syndrome mouse model. Pediatric Research 49(4 Part 2): 181A
Janisiewicz, W.J.; Tworkoski, T.J.; Kurtzman, C.P. 2001: Phenotypic, genetic and functional characterizing of Metchnikowia pulcherrima strains that control blue mold of apple. Phytopathology 91(6 Suppl): S43
Fernandez,E.; Alegria,A.; Delgado,S.; Mayo,B. 2010: Phenotypic, genetic and technological characterization of Lactococcus garvieae strains isolated from a raw milk cheese. International Dairy Journal: 3, 142-148
Almeida, R.D.; Peluzio, J.M.; Afferri, F.S. 2010: Phenotypic, genotypic and environmental correlations in soybean cultivated under an irrigated meadow in south of Tocantins state. Bioscience Journal 26(1): 95-99
Cosentino, S.; Pisano, M.B.; Piras, C.; Corda, A. 2003: Phenotypic, genotypic and technological characteristics of lactococci isolated from traditional Fiore Sardo cheese. FEMS Congress of European Microbiologists Abstract Book 1: 107-108
Ilardi, P.; Abad, J.; Rintamäki, P.; Bernardet, J-F.; Avendaño-Herrera, R. 2010: Phenotypic, serological and molecular evidence of Chryseobacterium piscicola in farmed Atlantic salmon, Salmo salar L., in Finland. Journal of Fish Diseases 33(2): 179-181
Ferenci, P.; Berr, F.; Caca, K.; Firneisz, G.; Szalai, F.; Datz, C.; Stauber, R.; Vogel, W.; Polli, C.; Maier Dobersberger, T. 2000: Phenotypic-genotypic correlations of common mutations in European patients with Wilson disease. Hepatology 32(4 Pt 2): 415A
Keren, A.; Meiner, V.; Potekhin, M.; Galimidi, J.; Katz, A.; Weinstein, J.M.; Reisner, S.A.; Sharif, D.; Lorber, A.; Shaheen, J.; Roguin, A.; Klein, T.; Blondheim, D.; Vered, Z.; Leibowitz, D.; Shemesh, J.; Rein, A.J.J.T.; Peleg, E.; Dreyfus, M.J.; Leitersdo 2000: Phenotypic-genotypic findings in hypertrophic cardiomyopathy in the ISAAC national database. Journal of the American College of Cardiology 35(2 Suppl A): 202A
Makhdoom, Z.A.; Bross, R.J.; Kumar, A.; Ghosh, M.S.; Komar, M.J.; Varano, V.J.; Alomari, M.; Hamati, H. 2000: Phenotypic/genotypic correlations in hereditary hemochromatosis Can phenotypic expression of HFE mutation always be correlated?. Hepatology 32(4 Pt 2): 490A
Rodriguez, M.; Gelvez, N.; Lattig, M.C.; Tamayo, M. 2002: Phenotypical analysis of an affected population with Waardenburg Syndrome in Colombia. American Journal of Human Genetics 71(4 Suppl): 282
Lopez Fuertes, L.; Campos, E.; Domenech, N.; Ezquerra, A.; Castro, J.M.; Dominguez, J.; Alonso, F. 2000: Phenotypical and functional analysis of macrophages infected with PRRS virus. Veterinary Research 31(1): 42-43
Colpaert, S.A.; Vanstraelen, K.; Liu, Z.; Ade, M.; Geboes, K.; Ceuppens, J.; Rutgeerts, P. 2000: Phenotypical and functional characterization of the Antigen Presenting Cell in Crohns disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1337
Nguyen, X.D.; Bugert, P.; Kropshofer, H.; Eichler, H.; Beck, C.; Klueter, H. 2003: Phenotypical and immungenetical analysis of CD14- and CD34-derived dendritic cells. Genes and Immunity 4(Suppl 1): S14
Bellmann, O.; Wegner, J.; Schneider, F.; Teuscher, F.; Ender, K. 2003: Phenotypical characterisation regarding growth, hormones, and meat quality in bulls of two types of cattle as a source for segregating family structures. Journal of Dairy Science 86(Suppl 1): 97
Ishida, Y.; Nakamura, M.; Ebihara, K.; Hoshino, K.; Hashiguchi, H.; Mitsuyama, Y.; Nishimori, T.; Nakahara, D. 2000: Phenotypical characterization of Fos-positive cells in brainstem monoaminergic nuclei following intracranial self-stimulation of the medial forebrain bundle in rat. Neuroscience Research Suppl (24): S48
Seitzer, U.; Ploetz, S.G.; Behrendt, H.; Simon, H.U.; Ring, J. 2000: Phenotypical characterization of infiltrating cells in skin lesions of patients suffering from hypereosinophilic syndrome Correlation with disease manifestation. Immunobiology 203(1-2): 556-557
Franssen, M.; Van, D.K.rkhof, P.; Van Erp, P. 2003: Phenotypical characterization of transit amplifying cells in normal human epidermis. Journal of Investigative Dermatology 121(1): 0472
Goerres, M.S.; Mulder, C.J.J.; Kerckhaert, J.A.M.; Van Dijk, H. 2002: Phenotypical differences in T-lymphocytes of non-coeliacs, coeliacs and refractory coeliacs; Association to enteropathy associated T cell lymphoma. Gastroenterology 122(4 Suppl 1): A-385
Tranchant, C.; Moreira, M.C.; Fleury, M.; Koenig, M.; Warter, J.M. 2002: Phenotypical heterogeneity in ataxia-ocular apraxia 1. Neurology 58(7 Suppl 3): A38-A39
Krone, N.; Schwarz, H.P. 2000: Phenotypical heterogeneity in congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency Two families, one genotype, two phenotypes. Hormone Research 53(Suppl 2): 70
Gorduza, E.V.; Angheloni, T.; Stoica, O.; Volosduc, M.; Covic, M. 1999: Phenotypical polymorphism in X trisomy. Cytogenetics and Cell Genetics 85(1-2): 149
Abecassis, S.; Giustiniani, J.; Guigne, E.; Bensussan, A.; Bagot, M. 2004: Phenotypical study of lymphocytes infiltrating the skin in atopic dermatitis after expansion ex vivo. Journal of Investigative Dermatology 123(2)
Dabir, T.; Mckee, S. 2003: Phenotypical variability in frontonasal dysplasia. Journal of Medical Genetics 40(Suppl 1): S39
Odent, S.; Blayau, M.; Lazaro, L.; De La Pintiere, A.; Aguilela, C.; Pasquier, L.; Dubourg, C.; David, V. 2001: Phenotypical variability in loci of holoprosencephaly. American Journal of Human Genetics 69(4 Suppl): 598
Metzke Heidemann, S.; Kaisenberg, H.K.hling Von; Caliebe, A.; Janssen, D.; Jonat, W.; Grote, W.; Kaisenberg, C.S.V.n 2004: Phenotypical variation in cousins with the identical partial trisomy 9 and 7 at 16 and 23 weeks gestation. American Journal of Medical Genetics 126A(2): 197-203
Ouachee Chardin, M.; Cavazzana Calvo, M.; Blanche, S.; Casanova, J.L.; Hirsch, I.; Caillat Zucman, S.; Fischer, A. 2003: Phenotypically HLA-matched related donor stem cell transplantation in children with inherited diseases A single center Study. Blood 102(11): 477a
Osawa, H.; Yamagami, S.; Tanaka, K.; Yamada, J.; Streilein, J.W. 2000: Phenotypically different T lymphocytes are activated when orthotopic corneal allografts and xenografts are rejected. IOVS Investigative Ophthalmology and Visual Science 41(4): S667
Abdrakhmanova, G.; Vlachova, V.; Vyklicky, L.Jr 2000: Phenotypically induced changes in the properties of glutamate receptors in rat spinal cord motoneurons. Physiological Research 49(4): P25
Crawford, E.; Creswick, H.; Keister, K.L.; Schwartz, S.; Proud, V.K.; Zackowski, J.L. 2003: Phenotypically normal child with a terminal deletion of 3p262. Genetics in Medicine 5(3): 229
Kramer, J.W.; Post, M.A.; Brown, A.M.; Kirsch, G.E. 1999: Phenotypically unique heteromeric channel formed when one Kv61 alpha-subunit coassembles with Kv21. Biophysical Journal 76(1 Part 2): A186
Hu, M.S.; Yeaman, G.; Collins, J.; Debbabi, H.; Kasper, L.H. 1999: Phenotyping and apoptosis of inflammatory cells within eyes of acquired ocular toxoplasmosis in C57BL/6 mice. IOVS Investigative Ophthalmology and Visual Science 40(4): S137
Caron, M.G. 2003: Phenotyping dopamine related behaviors and reward mechanisms in mice. FASEB Journal 17(4-5): Abstract 719
Zarif, L.; Covic, A.; Iyengar, S.; Sedor, J.; Schelling, J. 1999: Phenotyping hypertensive nephrosclerosis Is it really the most common cause of ESRD?. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 93A
Pietrobelli, A.; Miller, S.; Tan, Y.X.; Wang, Z.M.; Nunez, C.; Heymsfield, S.B. 1999: Phenotyping obese subjects Multi-contact electrode bioimpedance system for practical body composition measurement. FASEB Journal 13(4 Part 1): A259
Schrader, M.; Schulte, I.; Appelt, A.; Neitz, S.; Hess, R. 2002: Phenotyping of a diabetes animal model by peptidomics. Molecular and Cellular Proteomics 1(9): 724
Kuhn, I.; Iversen, A.; Bonjoch, X.; Wallis, J.; Ebdon, J.; Taylor, H.; Skraber, S.; Pissarides, N.; Papageorgiou, T.G.; Blanch, A.R. 2003: Phenotyping of bacterial populations A useful method for microbial source tracking. FEMS Congress of European Microbiologists Abstract Book 1: 77
Kerre, T.; De Smet, G.; De Smedt, M.; Offner, F.; Vandekerckhove, B.; Plum, J. 2000: Phenotyping of human spleen and bone marrow homed cells at several timepoints shortly after intravenous injection in Nod/Scid mice. Tissue Antigens 55(Suppl 1): 97-98
Morsy, M.A.; Norman, P.J.; Rela, M.; Heaton, N.D.; Vaughan, R.W. 2002: Phenotyping of intrahepatic T, NKT and NK cells in liver transplant recipients with end-stage alcohol related chronic liver disease. Hepatology 36(4 Part 2): 408A
Morsy, M.A.; Norman, P.J.; Rela, M.; Heaton, N.D.; Vaughan, R.W. 2001: Phenotyping of intrahepatic lymphocytes in human donor liver. Hepatology 34(4 Pt 2): 296A
Friedrich, M.; Krammig, S.; Doecke, W.D.; Sterry, W.; Asadullah, K. 2001: Phenotyping of lesional T-cells in psoriasis by flowcytometry, indicates an activated, memory/effector type 1 immunophenotype. Archives of Dermatological Research 293(1-2): 101
Pearce, D. 2003: Phenotyping of murine bone marrow side population cells. Experimental Hematology (New York) 31(7 Suppl 1): 78
Li, G.; Lambert, C.; Passebosc, K.; Armand, C.; Blanc, F.; Genin, C.; Tostain, J. 1999: Phenotyping of renal cell carcinoma infiltrating lymphocytes. European Urology 36(5): 475
Schulte, I.; Appel, A.; Hess, R.; Schrader, M.; Tammen, H.; Reiter, R. 2003: Phenotyping of the diabetic ob/ob-Mouse model by Peptidomics technologies. Diabetes and Metabolism 29(Hors serie 2): 4S95
Schulte, I.; Appel, A.; Neitz, S.; Hess, R.; Maehnss, K. 2003: Phenotyping of the ob/ob-mouse model by peptidomics. Diabetes 52(Suppl 1): A546
Joshua, D.; Pope, B.; Brown, R.; Brown, L.; Murray, A.; Gibson, J. 2002: Phenotyping primitive plasma cells. British Journal of Haematology 117(1): 252-253
Hemker, H.C.; Béguin, S. 2000: Phenotyping the clotting system. Thrombosis and Haemostasis 84(5): 747-751
Nislow, C.; Adams, C.; Schneiders, E.; Sigal, N.; Oestreicher, D.; Sabry, J.; Drubin, D.G. 2000: Phenotyping yeast using automated image acquisition and analysis on a genome-wide scale. Molecular Biology of the Cell 11(Suppl): 124a-125a
Mokry, J.; Karbanova, J. 2000: Phenotypization of cells yielded from two distinct culture systems for generation of neural progenitor cells. European Journal of Neuroscience 12(Suppl 11): 326
Harfenist, M.; Boros, E.; Heyer, D. 2000: Phenoxathin derivatives as inhibitors of monoamine oxidase. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)
Calderwood, D.J.; Fisher, A.J.; Jeffery, J.E.; Jones, C.G. Pryce; Rafferty, P. 2000: Phenoxy-, phenylthio-, benzoyl-alkyleneaminoalkylene-imidazole derivatives as therapeutic agents. Official Gazette of the United States Patent and Trademark Office Patents 1231(5)
Maroni, M.; Colosio, C.; Ferioli, A.; Fait, A. 2000: Phenoxyacetate herbicides. Toxicology 143(1): 77-83
Tanaka, N.; Tamai, T.; Mukaiyama, H.; Hirabayashi, A.; Muranaka, H.; Sato, M.; Akahane, M. 2003: Phenoxyacetic acid derivatives and medicinal compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)
Tanaka, N.; Goto, R.; Ito, R.; Hayakawa, M.; Sugidachi, A.; Ogawa, T.; Asai, F.; Fujimoto, K. 2000: Phenoxyalkylamines III Synthesis and selective serotonin-2 receptor binding. Chemical and Pharmaceutical Bulletin (tokyo). 48(11): 1729-1739
Frang, H.; Pihlavisto, M.; Cockcroft, V.; Scheinin, M.; Marjamaki, A. 2000: Phenoxybenzamine binds irreversibly to an exposed cysteine in the third transmembrane domain of the human alpha2-adrenoceptor. European Journal of Neuroscience 12(Suppl 11): 403
Adam, M.D.; Andrews, M.D.; Elliott, M.L.; Gymer, G.E.; Hepworth, D.; Howard, H.R. Jr; Middleton, D.S.; Stobie, A. 2003: Phenoxybenzylamine derivatives as SSRIs. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)
Bohn, S.; Bircher, A.J. 2001: Phenoxyethanol-induced urticaria. Allergy 56(9): 922-923
Uckun, F.M.; Venkatachalam, T.K. 2004: Phenoxyethyl-thiourea-pyridine compounds and their use for treatment of HIV-infections. Official Gazette of the United States Patent and Trademark Office Patents 1281(4)
Bigg, D.; Pommier, J.; Martin, C.; Roubert, P.; Defaux, J.P.erre 2003: Phenoxyethylamine derivatives having high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)
Bigg, D.; Galcera, M.O.ile 1999: Phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)
Cecchi, R.; Croci, T.; Guzzi, U.; Marsault, E. 2003: Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)
Loughhead, D.G.; Lin, X.F.; Weikert, R.J.; Flippin, L.A. 2000: Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)
Heil, Markus; Meier, Heinrich; Naab, Paul; Voerste, Arnd; De Vry, Jean Marie Viktor; Denzer, Dirk; Mauler, Frank; Lustig, Klemens; Lenfers, Jan Bernd 2004: Phenoxyphenyl alkanesulphonates. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)
Andrews, M.D.; Hepworth, D.; Middleton, D.S.; Stobie, A. 2003: Phenoxyphenylheterocyclyl derivatives as SSRIs. Official Gazette of the United States Patent and Trademark Office Patents 1275(1)
Nishiyama, A.; Bougauchi, M.; Kuroita, T.; Minoguchi, M.; Morio, Y.; Kanzaki, K. 2004: Phenoxypropylamine compounds. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)
Dorn-Beineke, A.; Hassan, A.-W.; Bräutigam, J.; Hildenbrand, R.; Dempfle, C.-E.; Schwab, M. 2003: Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapy. Thrombosis and Haemostasis 90(6): 1210-1213
Bux-Gewehr, I.; Zotz, R.B.; Scharf, R.E. 2000: Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorder. Thrombosis and Haemostasis 83(5): 799-800
Sorbera, L.A.; Castaner, J. 2003: Phenserine tartrate Treatment of alzheimers disease. Drugs of the Future 28(1): 18-25
Gorbenko, N.; Poltorak, V.; Gladkih, A. 2003: Phensuccinal improves beta-cell function in streptozotocin-treated newborn rats. Diabetes and Metabolism 29(Hors serie 2): 4S267
Gorbenko, N.; Poltorak, V.; Gladkich, A.; Leshchenko, Z.; Pivovarevich, L. 2001: Phensuccinal improves lipid profile and enhances paraoxonase activity in diabetic rabbits. Diabetologia 44(Suppl 1): A322
Maher, T.J.; Ulus, I.H.; Wurtman, R.J. 1999: Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines. Lancet 353(9146): 38
Maher, T.J. 2000: Phentermine's effect on serotonin in plasma?. American Journal of Cardiology 86(7): 810-811
Burns, M.; Dickson, E.; Sivilotti, M.; Cuenoud, H. 1999: Phentolamine antagonism of phenylpropanolamine-induced mortality. Journal of Toxicology. Clinical Toxicology 37(5): 630
Kooijman, M.; Rongen, G.A.; Smits, P.; Hopman, M.T.E. 2002: Phentolamine as a tool to study the contribution of alpha-adrenoceptor stimulation to basal thigh vascular tone. Medicine and Science in Sports and Exercise 34(5 Suppl): S30
Hoffman, R.P.; Dopp, J.M.; Sinkey, C.A.; Phillips, B.G. 2001: Phentolamine augments hyperinsulinemic vasodilation but does not alter muscular glucose uptake. Diabetes 50(Suppl 2): A328
Hoy, M.; Bokvist, K.; Weng, X.G.; Hansen, J.; Buschard, K.; Gromada, J. 2000: Phentolamine inhibits exocytosis by G12 protein-dependent activation of calcineurin in rat pancreatic A-cells. Diabetologia 43(Suppl 1): A118
Hatzichristou, D.G.; Apostolidis, A.; Tzortzis, V.; Hatzimouratidis, K.; Kouvelas, D. 2001: Phentolamine mesylate administered per os, enhances nocturnal erectile activity. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R133
Reinke, L.A.; Moore, D.R.; Sang, H.; Janzen, E.G.; Kotake, Y. 1999: Phenyl N-t-butylnitrone hydroxylation by cytochrome P-450 and hydroxyl radicals. Free Radical Biology and Medicine 27(Suppl 1): S133
Kotake, Y.; Sang, H.; Wallis, G.L.; Stewart, C.A. 1999: Phenyl N-tert-butylnitrone provides protection from endotoxin shock through amplified production of the anti-inflammatory cytokine interleukin-10. Archives of Biochemistry and Biophysics 371(1): 129-131
Goodson, T., J.; Harper, R.W.; Herron, D.K. 2002: Phenyl acetamides as sPLA2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1256(1)
Ziegler, H.; Trah, S.; Farooq, S.; Zurfluh, R. 2001: Phenyl acetic acid derivatives as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1252(1)
Fobare, W.F.; Freymuller, J. 2002: Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Official Gazette of the United States Patent and Trademark Office Patents 1258(4)
Bromidge, S.M.; Clarke, S.E.; Gager, T.; Griffith, K.; Jeffrey, P.; Jennings, A.J.; Joiner, G.F.; King, F.D.; Lovell, P.J.; Moss, S.F.; Newman, H.; Riley, G.; Rogers, D.; Routledge, C.; Serafinowska, H.; Smith, D.R. 2001: Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists Identification of N- -4-methoxy-3-piperazin-1-ylbenzenesulfonamide. Bioorganic and Medicinal Chemistry Letters 11(1): 55-58, 8 January
Christophersen, P.; Pedersen, O. 2002: Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers. Official Gazette of the United States Patent and Trademark Office Patents 1260(2)
Xiang, J.N.; Macpherson, D.T.; Corbett, D.F.; Elliott, J.D. 2000: Phenyl derivatives useful as endothelin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)
Goodson, T., J.; Harper, R.W.; Herron, D.K. 1999: Phenyl glyoxamides as SPLA2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1223(5)
Andersson, P.G.; Hedberg, C. 2004: Phenyl inden-1-one compounds. Official Gazette of the United States Patent and Trademark Office Patents 1286(2)
Lai, C.S.; Tiekink, E.R.T. 2003: Phenyl mercury. Applied Organometallic Chemistry 17(3): 194
Malamas, M.S.; Wrobel, J.E.; Dietrich, A.J.; Li, Z.; Gunawan, I. 2000: Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)
Nargund, R.; Barakat, K.; Rohrer, S.; Birzin, E.; Mellin, T.; Cashen, D.; Jacks, T.; Schleim, K.; Mosley, R.; Hickey, G.; Schaeffer, J.; Patchett, A. 2000: Phenyl piperidine-based orally active peptidomimetic agonists for somatostatin receptor subtype-2. Fields, Gregg B Author, Tam, James P Author, Barany, George Author Peptides for the new millennium 248-249
Andersson, P.G.; Hedberg, C. 2004: Phenyl propenone compounds. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)
Caldwell, C.G.; Chiang, Y C.; Dorn, C.; Finke, P.; Hale, J.; Maccoss, M.; Mills, S.; Robichaud, A. 1999: Phenyl spiroethercycloalkyl tachykinin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 545-546
Hahin, R.; Kondratiev, A. 1999: Phenyl substituted n-alkanols reduce Na currents by blocking, inactivating, and altering channel kinetics. Society for Neuroscience Abstracts 25(1-2): 1253
Bos, M.A.; Galley, G.; Godel, T.; Hoffmann, T.; Hunkeler, W.; Schnider, P.; Stadler, H. 2002: Phenyl substituted pyridine and benzene derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)
Koizumi, N.; Okada, M.; Iwashita, S.; Takegawa, S.; Nakagawa, T.; Takahashi, H.; Fujii, T. 2004: Phenyl sulfamate derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1284(2)
Murugesan, N.; Hunt, J.T. 2000: Phenyl sulfonamide endothelin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
Chan, G.L.; Johns, A.; Jurewicz, A.J.; Porter, R.A.; Widdowson, K.L. 2002: Phenyl urea and phenyl thiourea derivatives as HFGAN72 antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)
Coulton, S.; Johns, A.; Porter, R.A.an 2004: Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)
Widdowson, K.L.; Veber, D.F.; Jurewicz, A.J.; Hertzberg, R.P.; Rutledge, M.C., J. 2001: Phenyl urea antagonists of the IL-8 receptor. Official Gazette of the United States Patent and Trademark Office Patents 1245(1)
Baroni, M.; Bourrie, B.; Cardamone, R.; Casellas, P.; Guzzi, U. 2003: Phenyl- and pyridyl-tetrahydro-pyridines having TNF inhibiting activity. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)
Belley, M.; Gauthier, J.Y.; Grimm, E.; Leblanc, Y.; Li, C.S.; Therien, M.; Black, C.; Prasit, P.; Lau, C.K.; Roy, P. 1999: Phenyl-2- -furanones as COX-2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1228(2)
Leblanc, Y.; Roy, P.; Leger, S.; Grimm, E.; Wang, Z. 2000: Phenyl-2- -furanones with oxygen link as COX-2 inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)
Fuchs, K.; Stransky, W.; Grauert, M.; Carter, A.; Gaida, W.; Weiser, T.; Ensinger, H. 2004: Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines. Official Gazette of the United States Patent and Trademark Office Patents 1285(1)
Pruitt, J.R.; Fevig, J.M.; Quan, M.L.; Pinto, D.J. Phillip 2001: Phenyl-isoxazoles as factor XA Inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)
Hull, K.G.; Sidduri, A.; Tilley, J.W. 2002: Phenyl-keto-imidazolidine thioamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1264(2)
Xi, N.; Xu, S.; Zhu, J.; Arvedson, S.; Zhang, J.; Osslund, T.; Dominguez, C. 2001: Phenyl-lactam structure as mimetic of peptide turn. Abstracts of Papers American Chemical Society 221(1-2): ORGN 80
Ziegler, H.; Zurfluh, R. 2002: Phenyl-methoxyimino-glyoxylic acid derivatives as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)
Hendricks, M L.; Van, D., G.C.E.; Van, D., P.J.V.; Van, D., G.K.L.; Ndrebosmans, J P.R.; Verdonck, M.G.C. 1999: Phenyl-oxo-alkyl- benzoate derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2523-2524
Coghlan, R.D.; Fobare, W.F. 2003: Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)
Meier, Heinrich; Hartwig, Wolfgang; Junge, Bodo; Schohe Loop, Rudolf; Gao, Zhan; Schmidt, Bernard; De Jonge, Maarten; Schuurman, Teunis 2001: Phenyl-substituted 1,4-dihydropyridines. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)
Adam, G.; Kolczewski, S.; Mutel, V.; Wichmann, J.; Woltering, T.J.hannes 1999: Phenyl-substituted 5H-thiazolo pyrimidine derivative glutamate receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)
Schwark, J.R.; Kleemann, H.W.; Lang, H.J.; Weichert, A.; Scholz, W.; Albus, U. 2000: Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them. Official Gazette of the United States Patent and Trademark Office Patents 1231(3)
Schwark, J.R.; Brendel, J.; Kleemann, H.W.; Lang, H.J.; Weichert, A.; Jansen, H.W.; Scholz, W. 1999: Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)
Afonso, A.; Kelly, J.M.; Weinstein, J.; Wolin, R.L.; Rosenblum, S.B. 2001: Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)
Cavalla, D.J.; Chasin, M.; Dolby, L.J.; Frith, R.W. 2001: Phenyl-triazole compounds for PDE-IV inhibition. Official Gazette of the United States Patent and Trademark Office Patents 1247(3)
Park, N.S.; Jung, Y.S.; Seong, C.M.; Choi, S.W.; Choi, Y.J.; Lee, J.C.; Choi, J.I.; Lee, K.S.; Kong, J.Y.; Lee, B.Y.; Kim, J.H. 1999: Phenylacetamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)
Pevarello, P.; Orsini, P.; Traquandi, G.; Brasca, M.G.; Amici, R.; Villa, M.; Piutti, C.; Varasi, M.; Longo, A. 2002: Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)
Protiva, P.; Agarwal, B.; Holt, P.R. 2001: Phenylacetate enhances the effect of chemotherapy on colon cancer cells. Gastroenterology 120(5 Suppl 1): A 616
Waldbillig, R.J.; Mrowczynski, E.; Burzynski, S. 2003: Phenylacetic acid and phenylacetylglutamine Mechanism of uptake and changes in epigenetic-mechanisms regulating gene expression. Cancer Epidemiology Biomarkers and Prevention 12(11 Part 2): 1289s-1290s
Grell, W.; Hurnaus, R.; Sauter, R.; Reiffen, M.; Rupprecht, E. 2000: Phenylacetic acid benzylamides. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)
Burzynski, S.R. 2000: Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)
Bayer, H.; Sauter, H.; Mueller, R.; Grammenos, W.; Harreus, A.; Kirstgen, R.; Roehl, F.; Ammermann, E.; Lorenz, G. 1999: Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them. Official Gazette of the United States Patent and Trademark Office Patents 1220(5): 4606-4607
Bayer, H.; Sauter, H.; Oberdorf, K.; Grammenos, W.; Grote, T.; Kirstgen, R.; Muller, B.; Muller, R.; Rohl, F.; Ammermann, E.; Harries, V.; Lorenz, G.; Strathmann, S.; Gotz, N.; Harreus, A. 2003: Phenylacetic acid derivatives, process and intermediate products for their preparation, and their use as fungicides and pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)
Muller, B.; Sauter, H.; Bayer, H.; Grammenos, W.; Grote, T.; Kirstgen, R.; Oberdorf, K.; Rohl, F.; Gotz, N.; Rack, M.; Muller, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2001: Phenylacetic acid derivatives, process for their preparation and their use as pesticides and fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1248(4)
Grote, T.; Bayer, H.; Muller, R.; Sauter, H.; Kirstgen, R.; Harries, V.; Lorenz, G.; Ammermann, E.; Strathmann, S. 2000: Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them. Official Gazette of the United States Patent and Trademark Office Patents 1232(2)
Grote, T.; Bayer, H.; Muller, R.; Sauter, H.; Kirstgen, R.; Harries, V.; Lorenz, G.; Ammermann, E.; Strathmann, S. 1999: Phenylacetic acid derivatives, processes and intermediates for use in producing them and agents containing them. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Heil, M.; Militzer, H.C.; Bretschneider, T.; Alig, B.; Mauler Machnik, A.; Stenzel, K.; Wachendorff Neumann, U. 2002: Phenylacetic acid heterocyclyl amides having an insecticidal effect. Official Gazette of the United States Patent and Trademark Office Patents 1259(2)
Liang, C.D.; Mckearn, J.P.; Farah, J.M.Jr; Mueller, R.A. 2002: Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)
Gledhill, L.; Greaves, P.A.; Griffin, J.P. 2001: Phenylacetyl-CoA ligase from penicillium chrysogenum. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)
Fukumoto, K.; Kohno, S.; Kanoh, K.; Asari, T.; Kawashima, H.; Sekiya, H.; Ohmizo, K.; Harada, T. 2002: Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)
Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I. 1999: (-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization. Journal of Antibiotics 52(2): 134-141
Parales, R.E.; Lee, K.; Resnick, S.M.; Gibson, D.T. 1999: Phenylalanine 352 controls the regioselectivity and enantioselectivity of cis-dihydroxylation reactions catalyzed by naphthalene dioxygenase. Abstracts of the General Meeting of the American Society for Microbiology 99: 579
Yoshida, R.K.; Kootstra, A.B. 2002: Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)
Head, J.C.; Porter, J.R.; Warrellow, G.J.; Archibald, S.C.; Hutchinson, B.W. 2004: Phenylalanine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)
Konradi, A.W.; Pleiss, M.A.; Thorsett, E.D.; Ashwell, S.; Welmaker, G.S.; Kreft, A.; Sarantakis, D.; Dressen, D.B.; Grant, F.S.; Semko, C.; Xu, Y.Z. 2004: Phenylalanine derivatives as alpha 4 integrin inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)
Hainline, B.E. 1999: Phenylalanine free protein. Official Gazette of the United States Patent and Trademark Office Patents 1229(3)
Richardson, Mary Ann 2001: Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)
Gianni, M.L.; Fiori, L.; Lammardo, A.M.; Fiege, B.; Verduci, E.; Racchi, E.; Rossi, S.; Giovannini, M. 2001: Phenylalanine hydroxylase mutations and phenylalanine-tyrosine metabolism in heterozygotes for phenylketonuria. Journal of Inherited Metabolic Disease 24(Suppl 1): 25
Huijbregts, S.C.J.; De Sonneville, L.M.J.; Licht, R.; Van Spronsen, F.J.; Sergeant, J.A. 2001: Phenylalanine levels between ages 25 and 7 predict neuropsychological outcome between ages 7 and 14 in treated phenylketonuria. Journal of Inherited Metabolic Disease 24(Suppl 1): 15
Ravi, S.; Lu, N.C.; Belo, P.; Sucher, K. 2002: Phenylalanine requirement and its biosynthesis in C elegans. FASEB Journal 16(4): A259
Courtney Martin, G.; Rafii, M.; Ball, R.O.; Clarke, J.T.R.; Bross, R.; Pencharz, P.B. 1999: Phenylalanine requirement in children with classical phenylketonuria. FASEB Journal 13(4 Part 1): A568
Ost, T.W.B.; Miles, C.S.; Munro, A.W.; Reid, G.A.; Chapman, S.K. 2001: Phenylalanine-393 Controlling the electronic properties of the heme in flavocytochrome P450 BM3. Biochemical Society Transactions 29(1): A37
Bula, C.M.; Bishop, J.E.; Norman, A.W. 2003: Phenylalanine-406 may act to stabilize the open conformation of the nuclear vitamin D receptor. FASEB Journal 17(4-5): Abstract 652
Harriman, G.; Schwender, C.; Gallant, D.; Cochran, N.; Briskin, M. 1999: Phenylalanine-based integrin-cell adhesion molecule antagonists. Abstracts of Papers American Chemical Society 218(1-2): MEDI 64
Carr, N.G.; Mann, N.H. 2002: Phenylalanine-free protein and DNA coding therefor. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)
Sidduri, A.; Tilley, J.W.ight 2002: Phenylalaninol derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1260(3)
Jaworski, D.D.; Lawlor, E.J.; Wang, M. 1999: Phenylalanyl tRNA synthetase alpha subunit polynucleotides from Streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2482
Jaworski, D.D.; Lawlor, E.J.; Wang, M. 2000: Phenylalanyl tRNA synthetase from streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Lawlor, Elizabeth Jane 2001: Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)
Hodgson, J.E.; Lawlor, E.J. 1999: Phenylalanyl-tRNA synthetase from Staphylococcus aureus. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Konno, M.; Nakae, T.; Hamanaka, N. 1999: Phenylalkan oic acid. Official Gazette of the United States Patent and Trademark Office Patents 1229(2)
Masuda, K.; Urushibata, I.; Asahara, T.; Furuse, K.; Kojima, Y.; Abe, H. 2000: Phenylalkane amide derivatives and agricultural or horticultural fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)
Porter, J.R.; Warrellow, G.J.; Archibald, S.C.; Head, J.C. 2003: Phenylalkanoic acid derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1268(3)
Kim, Y.K.; Seo, S.Y.; Heo, J.; Choi, Y.M. 2003: Phenylalkyl diamine as sigma receptor ligands Structure-activity relationship and potential anti-depressant activity. Abstracts of Papers American Chemical Society 226(1-2): MEDI 152
Cardinal, H.; Virdis, A.; Ghiadoni, L.; Haq, B.A.; Taddei, S.; Salvetti, G.; Salvetti, A. 2000: Phenylalkylamine calcium antagonist improves endothelium-dependent vasodilation by restoring nitric oxide availability in essential hypertensive patients. American Journal of Hypertension 13(4 Part 2): 242A
Huber, I.G.; Sinnegger, M.J.; Koschak, A.; Waldschuetz, R.; Pongs, O.; Striessnig, J. 2002: Phenylalkylamine interaction with transmembrane segment IIIS5 of L-type Ca2+ channel alpha1C subunits. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R58
Choi, Y.M.; Byun, J.K. 1999: Phenylalkylaminoalcohol carbamates and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)
Yanagisawa, H.; Takamura, M.; Fujita, T.; Fujiwara, T. 2000: Phenylalkylcarboxylic acid compounds and compositions for treating hyperglycemia. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)
Anderskewitz, R.; Schromm, K.; Renth, E.O.; Birke, F.; Jennewein, H.M.; Meade, C.J. Montague; Ding, A. 2000: Phenylamidine derivatives, a process for preparing the same and their use as medicaments. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)
Tanaka, K.; Nishida, T.; Nakano, J.; Inoue, M.; Nakamura, T.; Debuchi, H. 2000: Phenylamidinothiophene derivatives and anti-inflammatory agent containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1233(2)
Tamai, T.; Tanaka, N.; Mukaiyama, H.; Hirabayashi, A.; Muranaka, H.; Sato, M.; Akahane, M. 2002: Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same. Official Gazette of the United States Patent and Trademark Office Patents 1256(1)
Beeley, N.R.bert Arnold; Millican, T.A.drew 2000: Phenylaminocarbonyl derivatives and processes for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)
Sahara, N.; Takeshita, A.; Kobayashi, M.; Shigeno, K.; Nakamura, S.; Shinjo, K.; Naito, K.; Ohnishi, K.; Naoe, T.; Ohno, R. 2002: Phenylarsine Oxide More Intensely Induces Apoptosis in ATRA- and As2O3-Resistant APL Cell Lines Than As2O3 by Activating the Mitochondrial Pathway. Blood 100(11): Abstract No. 2134
Gerhard, R.; Just, I.; John, H. 2002: Phenylarsine oxide crosslinks cysteine residues within the GTP-binding region of the RhoA GTPase. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R147
Takahashi, H.; Suzuki, K.; Namiki, H. 2002: Phenylarsine oxide induces reverse translocation of PMA-activated PKCbetaII. Zoological Science 19(12): 1436
Umeda, N.; Mochizuki, N.; Uchida, S.; Nishibe, T.; Yamada, H.; Ito, K.; Horikoshi, H. 2002: Phenylazole compounds, process for producing the same and drugs for hyperlipemia. Official Gazette of the United States Patent and Trademark Office Patents 1254(5)
Harrison, T.; Sparey, T.J.; Teall, M.R. 2000: Phenylbenzimidazole derivatives as ligands for GABA receptors. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)
Stolowitz, M.L. 1999: Phenylboronic acid complexing reagents derived from aminosalicylic acid. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)
Green, G. 2003: Phenylbutazone carrier formulation. Official Gazette of the United States Patent and Trademark Office Patents 1269(4)
Pastor, J.; Zamarron, E.; Marinero, P.; Del Nozal, M.; Carrasco, B.; De La Rua, E. 1999: Phenylbutazone solved in silicone oil reduces lipid peroxidation from retina and lens in rabbits. IOVS Investigative Ophthalmology and Visual Science 40(4): S869
Clarke, K.; Feinman, R.; Harrison, L.E. 2001: Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB. Proceedings of the American Association for Cancer Research 42: 636
Terni, P.; Mairani, L.; Mandelli, G.; Pagella, P.G.; Marchesini, D.; Mariorana, S.; Brufani, M. 1999: Phenylcarbamate derivatives suitable to the use as anticholinesterase substances. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1584
Brossi, A.; Brzostowska, M.; Rapoport, S.; Greig, N. 1999: Phenylcarbamates of -eseroline, -N1-noreseroline and -N1-benzylnoreseroline selective inhibitors of acetyl and butyrylcholinesterase, pharmaceutical compositions and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)
Bayer, H.; Muller, B.; Muller, R.; Sauter, H.; Grote, T.; Grammenos, W.; Kirstgen, R.; Oberdorf, K.; Ptock, A.; Gotz, N.; Rack, M.; Rohl, F.; Ammermann, E.; Harries, V.; Lorenz, G.; Strathmann, S. 2000: Phenylcarbamates, methods for preparing them and agents containing them. Official Gazette of the United States Patent and Trademark Office Patents 1239(2)
Muller, B.; Sauter, H.; Bayer, H.; Grammenos, W.; Grote, T.; Kirstgen, R.; Oberdorf, K.; Rohl, F.; Gotz, N.; Rack, M.; Muller, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2000: Phenylcarbamates, processes and intermediate products for their preparation and their use as pesticides and fungicides. Official Gazette of the United States Patent and Trademark Office Patents 1235(2)
Karamloo, F.; Lewis, N.G.; Wangorsch, A.; Haustein, D.; Vieths, S. 2001: Phenylcoumaran benzylic ether reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Journal of Allergy and Clinical Immunology 107(2): S185
Stolowitz, M.L.; Kesicki, E.A.; Lund, K.P.; Hughes, K.A. 2002: Phenyldiboronic acid reagents and complexes. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)
Ulrich, Wolf Rudiger 1999: Phenyldihydrobenzofuranes. Official Gazette of the United States Patent and Trademark Office Patents 1222(2)
Tewari, N.; Ramesh; Gupta, S.; Tripathi, R.P. 2003: Phenylene bridged bis-glycosyl ureides as potential antileishmanial agents. Medicinal Chemistry Research 12(6-7): 314-315
Arnt, L.; Tew, G.N. 2002: Phenylene ethynylene polymers with amphiphilic structures. Abstracts of Papers American Chemical Society 224(1-2): POLY 559
Nishino, C.; Adachi, K.; Miyazawa, K.; Inada, R.; Otake, T. 2000: Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)
Keys, J.R.; Koch, W.J.; Eckhart, A.D. 2001: Phenylephrine -induced cardiac hypertrophy is mediated by the vascular system. FASEB Journal 15(4): A481
Kawabe, T.; Hu, J.; Harris, P.D.; Garrison, R.N.al 2001: Phenylephrine -induced vessel contraction is enhanced by PE-released constrictor prostanoid. FASEB Journal 15(4): A113
Zhao, N.; Ingenito, S.; Sica, A.L.; Gootman, P.M. 2002: Phenylephrine evoked dysrhythmias in developing swine with surgically-induced asymmetric autonomic cardiac innervation. FASEB Journal 16(4): A119
Xiao, Y.hui; Zhang, Lubo 2003: Phenylephrine induces apoptosis in cultured bovine endocardial endothelial cells role of c-myc and bcl-2. FASEB Journal 17(4-5): Abstract 412
Boer, Christa; Scheffer, Gert Jan; De Lange, Jaap J.; Westerhof, Nico; Sipkema, Peter 1999: Phenylephrine induces nitric oxide release in rat pulmonary arteries. FASEB Journal 13(4 Part 1): A100
Ikeda, T.; Ozaki, M.; Ikeda, K.; Sessler, D.I.; Sato, S. 1999: Phenylephrine infusion decreases the magnitude of redistribution hypothermia. Anesthesiology 91(3A): A523
Shapira, Y.; Talmor, D.; Merkind, V.; Artru, A.A.; Shapiro, O. 1999: Phenylephrine or large volume of saline given IV worsens outcome in a rat model of closed head trauma combined with uncontrolled hemorrhage. Anesthesiology 91(3A): A829
Davies, A.; Taylor, P.M.; Proud, C.G. 2000: Phenylephrine stimulation of growth in adult cardiomyocytes is dependent upon p38 MAP kinase. FASEB Journal 14(4): A583
Nash, P.J.; Stewart, W.J. 2002: Phenylephrine stress echocardiography A new pharmacologic test to evaluate mitral regurgitation. Journal of the American College of Cardiology 39(5 Suppl A): 371A
Acosta, F.; Sansano, T.; Contreras, R.F.; Reche, M.; Roques, V.; Beltran, R.; Rodriguez, M.A.; Robles, R.; Bueno, F.S.; Ramirez, P.; Parrilla, P. 1999: Phenylephrine treatment of the postreperfusion syndrome in liver transplantation. Transplantation Proceedings 31(6): 2373-2374
Kawabe, T.; Harris, P.D.; Garrison, R.N.al 2000: Phenylephrine triggers induction of agents to blunt vascular reactivity and contraction over time. FASEB Journal 14(4): A416
Kawabe, T.; Beach, K.P.; Harris, P.D.; Spain, D.A.; Garrison, R.N. 2000: Phenylephrine-induced contraction is limited by NOS1+3 and NOS2 at low and high preloads. FASEB Journal 14(4): A416
Cui, J.; Wilson, T.E.; Crandall, C.G. 2002: Phenylephrine-induced elevations in blood pressure is attenuated in heat stressed humans. Medicine and Science in Sports and Exercise 34(5 Suppl): S59
Stocker, S.D.; Schiltz, J.C.; Stricker, E.M.; Sved, A.F. 2000: Phenylephrine-induced increases in arterial blood pressure inhibit thirst but not vasopressin secretion in rats. FASEB Journal 14(4): A371
Saeed, A.E.; Parmentier, J.H.; Malik, K.U. 2001: Phenylephrine-induced inhibition of cell proliferation is mediated by a mechanism independent of cyclic AMP in rat-1 fibroblasts expressing alpha-1 adrenergic receptors. FASEB Journal 15(4): A565
Olivier,D.K.; Shikanga,E.A.; Combrinck,S.; Krause,R.W.M.; Regnier,T.; Dlamini,T.P. 2010: Phenylethanoid glycosides from Lippia javanica. South African Journal Of Botany: 1, 58-63
Freeman, J.G.; Ryan, J.J.; Hu Li, J.; Stewart, J.K. 1999: Phenylethanolamine N-methyl transferase mRNA in lymphoid cells. FASEB Journal 13(4 Part 1): A57
Tai, T.-C.; Wong, D.L. 2002: Phenylethanolamine N-methyltransferase gene regulation by cAMP-dependent protein kinase a and protein kinase C signaling pathways. Annals of the new York Academy of Sciences 971: 83-85
Kitazawa, M.; Okazaki, K.; Tamai, T.; Saito, M.; Tanaka, N.; Kobayashi, H.; Kikuchi, K.; Muranaka, H. 2000: Phenylethanolaminotetralincarboxamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1233(1)
Chorev, M.; Goren, T.; Herzig, Y.; Sterling, J.; Weinstock Rosin, M.; Youdim, M.B.H. 2001: Phenylethylamine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1247(4)
Anderskewitz, R.; Birke, F.; Jennewein, H.M. 2000: Phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)
Wikstrom, H.; Dijkstra, D.; Venhuis, B.J.han 2004: Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)
Mutel, V.; Peters, J.U.; Wichmann, J. 2004: Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles. Official Gazette of the United States Patent and Trademark Office Patents 1280(3)
Baker, S.R.; Clark, B.P.; Goldsworthy, J.; Harris, J.R. 1999: Phenylglycine derivatives useful for treating disorders of the central nervous system. Official Gazette of the United States Patent and Trademark Office Patents 1218(4): 3140-3141
Claussner, A.; Goubet, F.; Teutsch, J.G.orges 2001: Phenylimidazolidines containing nitrooxy or carbonyloxy groups. Official Gazette of the United States Patent and Trademark Office Patents 1247(1)
Castro Pineiro, J.L.; Hutchins, S.M.; Lewis, S.J.; Rowley, M.; Smith, A.L.; Stevenson, G.I. 2002: Phenylindole derivatives as 5-HT2A receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)
Lacolla, P.; Artico, M.; Sommadossi, J.P.erre 2004: Phenylindoles for the treatment of HIV. Official Gazette of the United States Patent and Trademark Office Patents 1280(4)
Quideau, S.; Pouysegu, L.; Oxoby, M.; Looney, M.A. 2001: Phenyliodine -mediated oxidative activation of 2-alkoxyarenols for carbon-oxygen, carbon-nitrogen and carbon-carbon bond formations. Abstracts of Papers American Chemical Society 221(1-2): ORGN 640
Olivera, R.; Sanmartin, R.; Pascual, S.; Herrero, M.; Dominguez, E. 1999: Phenyliodine bis mediated synthesis of phenanthro fused isoxazoles and pyrimidines. Tetrahedron Letters 40(17): 3479-3480
Grammenos, W.; Sauter, H.; Bayer, H.; Grote, T.; Gypser, A.; Kirstgen, R.; Muller, B.; Ptock, A.; Rohl, F.; Gotz, R.; Lorenz, G.; Ammermann, E.; Strathmann, S.; Harries, V. 2001: Phenylketiminooxybenzyl compounds, method for the production and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)
Cederbaum, S. 2002: Phenylketonuria: an update. Current Opinion in Pediatrics 14(6): 702-706
Weglage, J.; Grenzebach, M.; Denecke, J.; Koch, H.G.; Feldmann, R. 2002: Phenylketonuria Early treated young adults are not able to estimate their blood phenylalanine levels accurately. Journal of Inherited Metabolic Disease 25(Suppl 1): 9
Perez, B.; Pey, A.; Gamez, A.; Desviat, L.R.; Ugarte, M. 2001: Phenylketonuria Genotype-phenotype correlations based on expressed activity of 18 mutant proteins. American Journal of Human Genetics 69(4 Suppl): 480
Cerone, R.; Schiaffino, M.; Gianotti, D.; Veneselli, E.; Lorini, R. 2000: Phenylketonuria Is diet for life necessary?. Journal of Inherited Metabolic Disease 23(Suppl 1): 33
Walter, J.H.; White, F.J.; Hall, S.K.; Macdonald, A.; Rylance, G.; Boneh, A.; Francis, D.E.; Shortland, G.J.; Schmidt, M.; Vail, A. 2002: Phenylketonuria Is it possible to comply with current recommendations for dietary control? An audit from 4 major regional centres. Lancet (North American Edition) 360(9326): 55-57
Feldman, R.; Denecke, J.; Pietsch, M.; Grenzebach, M.; Weglage, J. 2001: Phenylketonuria No long term frontal lobe dependent deficits of early treated patients in comparison to diabetic patients. Journal of Inherited Metabolic Disease 24(Suppl 1): 17
Feldmann, R.; Denecke, J.; Pietsch, M.; Grenzebach, M.; Weglage, J. 2000: Phenylketonuria No specific frontal lobe dependent deficits of early treated patients in comparison to diabetic patients. Journal of Inherited Metabolic Disease 23(Suppl 1): 26
Maximova, S.P.; Mkheidze, M.O. 2001: Phenylketonuria Thirty years of observation in St Petersburg. Journal of Inherited Metabolic Disease 24(Suppl 1): 3
Stern, A.; Moseley, K. 2002: Phenylketonuria and IQ How many IQ points do we really need? Mental testing issues in treated PKU adults for future research. Journal of Inherited Metabolic Disease 25(Suppl 1): 9
Kalkanoğlu, H.S.; Anadol, D.; Yilmaz, E.; Coşkun, T. 2000: Phenylketonuria and cystic fibrosis in the same patient. Pediatrics International: Official Journal of the Japan Pediatric Society 42(1): 92-93
Bessman, S.P. 2001: Phenylketonuria heterozygosity as a cause of non-specific mental retardation. Pediatric Research 49(4 Part 2): 393A
Vallian, S.; Barahimi, E.; Shamoradgoli, M.; Hosseini, M.; Moeini, H. 2002: Phenylketonuria in Iran, the first report from the historical city of Isfahan. European Journal of Human Genetics 10(Suppl 1): 204
Hutchinson, D.K.; Brickner, S.J.; Barbachyn, M.R.; Taniguchi, M.; Munesada, K.; Yamada, H. 1999: Phenyloxazolidinone antimicrobials. Official Gazette of the United States Patent and Trademark Office Patents 1220(3): 2564-2565
Thomas, R.C.; Poel, T.J.; Barbachyn, M.R. 1999: Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)
Thomas, R.C.; Poel, T.J. 2002: Phenyloxazolidinones having a c-c bond 4-8 membered heterocyclic rings. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)
Gutterer, B. 2002: Phenylphennanthridines with PDE-IV inhibiting activity. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)
Ajito, K.; Murakami, S.; Ishikawa, M.; Yamamoto, M.; Kubota, D.; Gomi, S.; Hachisu, M.; Katano, K. 2002: Phenylpiperazine derivatives as integrin alphavbeta3 antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)
Vogt, T. 2010: Phenylpropanoid biosynthesis. Molecular Plant 3(1): 2-20
Solecka, D.; Kacperska, A. 2000: Phenylpropanoids and acclimation of winter oilseed rape plants to low temperature. Plant Physiology and Biochemistry (Paris) 38(Suppl): s174
Kim, S.R.; Lee, M.K.; Kim, Y.C.; Markelonis, G.J.; Oh, T.H. 1999: Phenylpropanoids from Scrophularia buergeriana protect cultured rat cortical neurons from glutamate-induced neurodegeneration. Society for Neuroscience Abstracts 25(1-2): 576
Phillips, C.V.; Goodman, K.J. 2001: Phenylpropanolamine banned based on what?. American Journal of Epidemiology 153(11 Suppl): S99
Matier, W.L.; Patil, S. 2001: Phenylpropionic acids and esters compounds and methods for inducing beta-blockade for the treatment of cardiac disorders. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)
Ohkuchi, M.; Kyotani, Y.; Shigyo, H.; Koshi, T.; Ohgiya, T.; Matsuda, T.; Kumai, N.; Kotaki, K. 2003: Phenylpyridazine compounds and medicines containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)
Manley, P.W. 2000: Phenylpyridine derivatives useful as phosphodiesterase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1236(3)
Rho, M-Chual.; Lee, H.Sun.; Chang, K-Tae.; Song, H.Young.; Kwon, O.Eok.; Lee, S.Woong.; Ko, J.Suk.; Hong, S.Gyu.; Kim, Y-Kook. 2002: Phenylpyropene C, a new inhibitor of acyl-CoA: cholesterol acyltransferase produced by Penicillium griseofulvum F1959. Journal of Antibiotics 55(2): 211-214
Kelly, T.A.; Bormann, B.J.; Frye, L.L.; Wu, J.P. 2002: Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)
Agostinelli, Enzo; Turini, Paola; Befani, Olivia; Martone, Alessandro; Di Santo, Roberto; Costi, Roberta; Artico, Marino; Roux, Alessandra; La Torre, Francesco; Ferretti, Rossella; Gallinella, Bruno; Cirilli, Roberto 2003: Phenylpyrrolylethanoneamines related to kathinone, endowed with potent and highly selective anti-MAO-A activity. Amino Acids 25(2): 113
Carpy, A.J.M.; Haasbroek, P.P.; Oliver, D.W. 2003: Phenylpyruvic acid derivatives as enzyme inhibitors Therapeutic potential on MIF. Medicinal Chemistry Research 12(4-5): 163-164
Vaupel, A. 2003: Phenylserine derivatives as integrin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)
Panzeri, Achille; Nesi, Marcella; Di Salle, Enrico 1999: Phenylsubstituted 4-azasteroid fluoroderivatives. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)
Romero, A.G.; Leiby, J.A. 2000: Phenylsulfonamide-phenylethylamines useful as dopamine receptors. Official Gazette of the United States Patent and Trademark Office Patents 1237(3)
Lorenz, K.; Willms, L.; Bauer, K.; Bieringer, H. 2001: Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)
Blurton, P.; Burkamp, F.; Cheng, S.K. Fung; Fletcher, S.R.; Macleod, A.M.; Spinks, D.; Van Niel, M.B. 2003: Phenylsulphonyl derivatives as 5-HT receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)
Kramer, W.; Wachendorff Neumann, U.; Erdelen, C.; Turberg, A.; Mencke, N. 2000: Phenylthio-oxazoline compounds and their use as pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1231(4)
Johns, A.; Porter, R.A.an 2002: Phenylurea and phenylthio urea derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)
Alexieva, V.; Iliev, L.; Karanov, E. 1999: Phenylurea cytokinins-physiological and applied approaches. Biologia Plantarum 42(Suppl ): S81
Jordan, S.L.; Golden, M.D.; Henry, J.; Corbett, T.; West, C.; Hui, R.; Passarelli, J. 2002: Phenytoin ONLINE TDM assay performance on the Roche/Hitachi 917 analyzer. Clinical Chemistry 48(6 Suppl): A48
Bento, A.; Menezes, O.; Vinagre, C. 2001: Phenytoin and valproic acid determinations by two different methods Immulite 2000, DPC LA, and Opus, Dade Behring. Clinical Chemistry 47(S6): A73-A74
Dager, W.E. 2002: Phenytoin assay errors in uremia. Annals of PharmacoTherapy 36(5): 939-940
Liu, H.W.; Payne, H.R.; Brady, S.T. 1999: Phenytoin blocks the action of corticosterone on microtubule and synapse associated proteins. Journal of Neurochemistry 72(Suppl ): S58
Tan, E.K.; Chan, L.L.; Auchus, A.P. 2001: Phenytoin cerebellopathy without epilepsy. Acta Neurologica Scandinavica 104(1): 61-62
Cunningham, M.O.; Wood, S.J.; Jones, R.S.G. 1999: Phenytoin enhances spontaneous GABA-mediated inhibition in the rat entorhinal cortex. British Journal of Pharmacology 127(Proceedings Suppl ): 49P
Quiñones, M.D.; Valero, C.; Salcedo, M.; Sánchez, I.; Jerez, J.; Matorras, P. 1999: Phenytoin hypersensitivity syndrome with fatal evolution. Allergy 54(1): 83-84
Wang, H.; Faucette, S.; Graham, R.; Sueyoshi, T.; Negishi, M.; Lecluyse, E. 2003: Phenytoin induction of CYP3A4 and 2B6 involves a PXR-independent signaling pathway. Drug Metabolism Reviews 35(Suppl 2): 118
Bertholf, R.; Johannsen, L.; Verstraete, A.; De Bel, A.; Jones, J.; Sargent, D.; Luthe, H.; Oellerich, M.; Rhode, K.H.; Roeddiger, R.; Sauter, H.; Coffing, M.J. 2004: Phenytoin measured by kinetic interaction of microparticles in solution homogeneous immunoassay Multisite evaluation of the Roche OnLine TDM method. Clinical Chemistry 50(6, Suppl S, Part 2): A133-A134
Adar, L.; Bialer, M.; Blotnick, S.; Caraco, Y. 2003: Phenytoin metabolic ratio correlates with formation clearance of -7-OH-warfarin. Tulunay, F C, Orme, M European collaboration: Towards drug development and rational drug therapy: 171
Muszkat, M.; Kraselnikov, I.; Elami, A.; Caraco, Y. 2002: Phenytoin metabolic ratio correlates with warfarin dose requirement. Clinical Pharmacology and Therapeutics 71(2): P37
Addicks, W.J.; Duda, J.P.; Snider, D.A.; Benson, K.R. 2001: Phenytoin sodium pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)
Moddel, G.; Cucullo, L.; Marchi, N.; Bingaman, W.; Dombrowski, S.M.; Najm, I.; Janigro, D. 2003: Phenytoin suppresses epileptiform field potentials in human brain slices from patients with pharmacoresistant epilepsy despite increased expression of multidrug resistance 1 gene product P-glycoprotein. Epilepsia 44(Suppl 9): 244
Rosemergy, I.; Findlay, M. 2002: Phenytoin toxicity as a result of 5-fluorouracil administration. New Zealand Medical Journal 115(1159): U124
Gelineau Van Waes, J.; Bennett, G.D.; Finnell, R.H. 1999: Phenytoin-induced alterations in craniofacial development Involvement of the retinoic acid receptors. Teratology 59(6): 381
Sharif, R.N.; Yashpal, K.; Henry, J.L. 1999: Phenytoin-induced anti-hyperalgesia but not antinociception in the rat tail-flick test. Society for Neuroscience Abstracts 25(1-2): 1943
Onodera, K.; Atsushi, T.; Takashi, S.; Hideaki, M.; Hisashi, S. 1999: Phenytoin-induced osteopenia and its prevention with 1alpha D3 or 1alpha,25 2D3 in growing rats. Japanese Journal of Pharmacology 79(Suppl 1): 277P
Mannelli, M. 2003: Pheochromocytoma: a permanent challenge for the clinical endocrinologist. Journal of Endocrinological Investigation 26(5): 387-388
Ross, J.H. 2000: Pheochromocytoma. Special considerations in children. Urologic Clinics of North America 27(3): 393-402
Meraney, A.M.; Gill, I.S.; Bravo, E.L.; Novick, A.C. 1999: Pheochromocytoma co-existing with renal artery lesions Implications for laparoscopic adrenalectomy. Journal of Endourology 13(Suppl 1): A87
Koch, C.A.; Mauro, D.; Walther, M.M.; Linehan, W.M.; Vortmeyer, A.O.; Pacak, K.; Chrousos, G.P.; Zhuang, Z.; Lubensky, I.A. 2001: Pheochromocytoma in VHL disease A distinct histopathological phenotype of hereditary pheochromocytoma. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S25
Diamond, J.A. 2001: Pheochromocytoma in a symptomatic patient with severe hypertension upon anesthesia induction. American Journal of Hypertension 14(7 Part 1): 729-730
Correia, M.J.; Bogalho, M.J.; Lopes, L.O.; Cristina, M.L.; Campo, M.A.; Bordalo, A.D.; Santos, I.; Santos, A.I.; Pinho, B.; Silva, H.; Tuna, J.L.; Diaz, M. 1999: Pheochromocytoma included in multiple endocrine neoplasia type 2A A validation of the genetic screening. Circulation 100(18): 1; 33
Moran, M.E.; Lehr, D.J.; Zornow, D.H.; Kim, D.H.; Abrahams, H.M. 2001: Pheochromocytoma multisystem crisis Probable contraindication for laparoscopic adrenalectomy. Journal of Endourology 15(Suppl 1): A26
Wu, J.S.; Ahya, S.N.; Reploeg, M.D.; Singer, G.G.; Brennan, D.C.; Howard, T.K.; Lowell, J.A. 2000: Pheochromocytoma presenting as a giant cystic tumor of the liver. Surgery 128(3): 482-484
Brown, K.; Stork, C.; Cantor, R. 2001: Pheochromocytoma unmasked by imipramine. Journal of Toxicology. Clinical Toxicology 39(5): 490
Fitzgerald, P.T.; Young, W.F.J.; Ackerman, M.J. 2004: Pheochromocytomas and QT interval prolongation A case series of 50 patients. Journal of the American College of Cardiology 43(5 Suppl A): 141A
Mauro, D.J.; Walther, M.; Yousem, S.; Jaffe, R.; Zhuang, Z.; Klauser, R.D.; Linehan, W.M.; Lubensky, I.A. 1999: Pheochromocytomas in Von Hippel-Lindau disease Comparative histopathologic analysis with MEN2, familial, NOS and sporadic pheochromocytomas. Modern Pathology 12(1): 68A
Gillam, M.P.; Landsberg, L. 2002: Pheocliromocyroma. Molitch, Mark E Contemporary Endocrinology Challenging cases in endocrinology: 155-183
Spratt, T.E.; Larios, E.; Reed, J.; Albino, A.P. 2001: Pheomelanin precursors are more mutagenic than eumelanin precursors in Salmonella mutagenicity tests Implications for melanoma etiology. Proceedings of the American Association for Cancer Research 42: 807
Siffel, P.; Vacha, F. 2001: Pheophytin reduction and fluorescence quenching in reaction centre of photosystem II. Photosynthesis Research 69(1-3): 185-186
Christensen, T.A.; Hildebrand, J.G. 2002: Pheromonal and host-odor processing in the insect antennal lobe: how different?. Current Opinion in Neurobiology 12(4): 393-399
Seidelmann, K.; Ferenz, H.J. 2002: Pheromonal courtship inhibition in desert locusts, Schistocerca gregaria. Zoology (Jena) 105(Suppl 5): 29
Ichikawa, M. 2003: Pheromonal memory and reproduction. Neuroscience Research Suppl (26): S10
Morgan, C.; Cone, R.D. 2000: Pheromonal regulation of energy homeostasis in Syrian hamsters. FASEB Journal 14(4): A432
Howse, Philip Edwin 2002: Pheromone baits for social insects. Official Gazette of the United States Patent and Trademark Office Patents 1255(1)
Swasdipan, N.; Ebert, P.R. 1999: Pheromone binding protein gene regulation is correlated with behavioural specialisation in the honey bee. Society for Neuroscience Abstracts 25(1-2): 389
Witzgall, P.; Trematerra, P.; Liblikas, I.; Bengtsson, M.; Unelius, C.R. 2010: Pheromone communication channels in tortricid moths: lower specificity of alcohol vs. acetate geometric isomer blends. Bulletin of Entomological Research 100(2): 225-230
Kosted, P.; Sherwood, J. 2001: Pheromone derived peptides from Ustilago hordei competitively inhibit the native activity of the enzyme farnesyltransferase. Phytopathology 91(6 Suppl): S50
Knipple, D.C.; Roelofs, W.L.; Miller, S.J. 1999: Pheromone desaturases. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 488
Nagnan, L.M.illour, P.; Jacquin Joly, E.; Descoins, C. 2002: Pheromone detection and insect pests control. Comptes Rendus de l'Academie d'Agriculture de France 88(4): 33-38
Baum, M.J. 2002: Pheromone detection by the main olfactory system and mammalian gender recognition. Biology of Reproduction 66(Suppl 1): 93
Quong, D. 2003: Pheromone immobilized in stable hydrogel microbeads. Official Gazette of the United States Patent and Trademark Office Patents 1270(2)
Severin, F.F.; Hyman, A.A. 2002: Pheromone induces programmed cell death in S. cerevisiae. Current Biology: Cb 12(7): R233-R235
Mori,K.; Tashiro,T.; ZhaoBoGuang; Suckling,D.M.; El-Sayed,A.M. 2010: Pheromone synthesis Part 243 Synthesis and biological evaluation of -1-Ethyl-2-Methylpropyl 3,13-dimethylpentadecanoate, the major component of the sex pheromone of Paulownia bagworm, Clania variegata, and its stereoisomers. Tetrahedron: 14, 2642-2653
Mabbett, T. 2004: Pheromone trapping indoors - Location and situation. International Pest Control 46(3): 129-132
Carvalho, M.O.; Pereira, A.P.; Mexia, A. 2001: Pheromone traps for monitoring Lasioderma serricorne and Ephestia elutella in stored tobacco in Portugal. Phytoparasitica 29(Suppl): 78S-79S
Babalyan, V.V.; Novikov, S.N. 2001: Pheromone which suppresses spermatogenesis in laboratory mice is associated with urine protein fraction. Doklady Akademii Nauk 378(3): 407-409
Morgan, C.; Novotny, M.V.; Cone, R.D. 2003: Pheromone-induced aggression and preputial gland expression are altered in mice lacking the melanocortin-5 receptor. FASEB Journal 17(4-5): Abstract 793
James, D.G.; Faulder, R.J.; Vogele, B.; Moore, C.J. 2000: Pheromone-trapping of Carpophilus spp Fauna, abundance and seasonality in some Australian horticultural regions. Plant Protection Quarterly 15(2): 57-61
Ando, N.; Shimoyama, I.; Kanzaki, R. 2000: Pheromone-triggered flight motor patterns during free flight were measured by micro-radio transmitter system. Zoological Science 17: 115
Franz, J.T.; Schulz, S.; Fuhlendorff, J.; Masuch, G.; Bergmann, K.C.; Muesken, H. 2001: Pheromones A possible mite avoidance measure?. Allergy 56(Suppl 68): 178
Moynihan, J.A.; Karp, J.D.; Cohena, N.; Ader, R. 1999: Pheromones alter immunity Role of opioids. Neuroimmunomodulation 6(6): 422
Wyatt, T.D. 2003: Pheromones and animal behaviour Communication by smell and taste. Wyatt, Tristram D Author, Reprint Author Pheromones and animal behaviour: Communication by smell and taste i-xv, 1-391
Whittle, C.L.; Bowyer, R.T.; Duffy, L.K.; Drew, K.; Preti, G.; Clausen, T.P. 2002: Pheromones in urine of rutting male moose. Arctic Science Conference Abstracts 53: 240
Shinohara, K.; Morofushi, M.; Kimura, F. 2000: Pheromones that mediate menstrual synchrony in human female. Neuroscience Research Suppl (24): S6
Steinman, R.M.; Pizlo, Z.; Pizlo, F.J. 2000: Phi is not beta. IOVS Investigative Ophthalmology and Visual Science 41(4): S110
Horng, J.-C.; Raleigh, D.P. 2003: Phi-Values beyond the ribosomally encoded amino acids: kinetic and thermodynamic consequences of incorporating trifluoromethyl amino acids in a globular protein. Journal of the American Chemical Society 125(31): 9286-9287
Nobbio, A. 2004: Phial for distributing products, with an improved applicability. Official Gazette of the United States Patent and Trademark Office Patents 1280(5)
Chen, W.; Diers, B.W.; Nelson, R.L. 2001: Phialophora gregata strains pathogenic to resistance allele sources Rbs1 and Rbs3. Phytopathology 91(6 Suppl): S16
Snyder, D.S.; Slovak, M.L.; Bhatia, R.; Arber, D.A. 2002: Philadelphia Chromosome Negative Clones in Philadelphia Chromosome Positive CML Emerging Clinical Implications in Eight Cases. Blood 100(11): Abstract No. 4837
Grudeva, J.; Balatzenko, G.; Krustev, T.; Marichkov, D.; Stefanova, M. 2002: Philadelphia Variant, t , in a Case with Chronic Myeloid Leukemia. Blood 100(11): Abstract No. 4822
Lesesve, J.F.; Troussard, X.; Flandrin, G. 1999: Philadelphia chromosome and p190BCR/ABL rearrangements in myelodysplastic syndromes. Leukemia Research 23(Suppl 1): S45
Nalamolu, Y.; Ballester, O.F.; Hiemenz, J.; Satya Prakash, K.L.; Kulharia, A.S.; Manaloor, E.J.; Mazzella, F.; Kutlar, A. 2003: Philadelphia chromosome positive acute bi-lineage leukemia Originating from a Ph negative clone. Blood 102(11): 241b
Mann, G.; Haas, O.A.; Grumayer Panzer, E.R.; Dworzak, M.N.; Gadner, H. 2001: Philadelphia chromosome positive mature B-cell leukemia. Annals of Hematology 80(Suppl 2): S27
Advani, A.S. 2004: Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Research 28(6): 545-546
Radich, J.P. 2001: Philadelphia chromosome-positive acute lymphocytic leukemia. Hematology/Oncology Clinics of North America 15(1): 21-36
Scaradavou, A.; Broniscer, A.; Stevens, C.E.; Kurtzberg, J.; Rubinstein, P. 2002: Philadelphia-Chromosome Acute Lymphoblastic Leukemia in Children and Adolescents Outcome with Unrelated Placental Cord Blood Transplantation. Blood 100(11): Abstract No. 3377
Castro Arellano, I.; Zarza, H.; Medellin, R.A. 2000: Philander opossum. Mammalian Species 638: 1-8
Parama, A.; Iglesias, R.; Alvarez, M.F.; Leiro, J.; Aja, C.; Sanmartin, M.L. 2003: Philasterides dicentrarchi Experimental infection and possible routes of entry in farmed turbot. Aquaculture 217(1-4): 73-80, 17 March
Jenkins, A. 1999: Philereme vetulata new to Co Clare. Entomologist's Record and Journal of Variation 111(1): 9
Barcelona, J.F. 2002: Philippine pteridophyte collections as a resource for conservation planning. Fern Gazette 16(6-8): 307-312
Conde, B. 2004: Philippines mental health country profile. International Review of Psychiatry 16(1-2): 159-166
Hartdegen, R.W.; Gamble, K.C. 2002: Phillodryas baroni baroni Endoparasitism. Herpetological Review 33(2): 141
Stiebel, H. 1999: Philloscopus collybita - observation in the lower Eder valley in the mild winter of 1997/98. Vogelkundliche Hefte Edertal 25: 58-60
Argolo, Antonio Jorge Suzart; De Freitas, Marco Antonio 2002: Philodryas aestivus. Herpetological Review 33(3): 229
Moravec,F.; Fajer-Avila,E.J.; Bakenhaster,M. 2010: Philometra floridensis sp n from the ovary of red drum Sciaenops ocellatus off the coast of Florida, USA. Journal Of Helminthology: 1, 49-54
Moravec, F.; Van As, J.G. 2001: Philometroides africanus sp n , a new tissue parasite of the African pike Hepsetus odoe in Botswana. Folia Parasitologica (Ceske Budejovice) 48(2): 127-131
Smetana, A.; Herman, L.H. 1999: Philonthus immundus of Gyllenhal, a misidentification. The Coleopterists Bulletin 53(3): 297-298
Kurta, A.; Murray, S.W. 2000: Philopatry and migration of Indiana bats. Bat Research News 41(4): 125-126
Jorgensen, S.J.; Reeb, C.A.; Chapple, T.K.; Anderson, S.; Perle, C.; Van Sommeran, S.R.; Fritz-Cope, C.; Brown, A.C.; Klimley, A.Peter.; Block, B.A. 2010: Philopatry and migration of Pacific white sharks. Proceedings. Biological Sciences 277(1682): 679-688
Coulon, J. 2003: Philorhizus liguricus Sciaky 1990, a new species for the French fauna. Bulletin Mensuel de la Societe Linneenne de Lyon 72(4): 158-160
O'Connor,J.A.; Sulloway,F.J.; Robertson,J.; Kleindorfer,S. 2010: Philornis downsi parasitism is the primary cause of nestling mortality in the critically endangered Darwins medium tree finch. Biodiversity And Conservation: 3, 853-866
Araujo, P.B.; Leistikow, A. 1999: Philosciids with pleopodal lungs from Brazil, with description of a new species. Contributions to Zoology 68(2): 109-141
Flaherty,D. 2010: Philosophical approaches to risk of anaesthetic overdose. Veterinary Times: 7, 28-32
Lugowski, W. 2002: Philosophical foundations of the theories on the origin of life. Origins of Life and Evolution of the Biosphere 32(5-6): 516-517
Robbins,J.E.; Houston,E.; Dummer,G.M. 2010: Philosophies and expectations of wheelchair and stand-up collegiate basketball coaches. Journal Of Sport Behavior: 1, 42-62
Miyawaki, A. 2001: Philosophy and practice of ecology in Japan in special regards to forest restoration. Ecological Society of America Annual Meeting Abstracts 86: 27
Stevens, Michael, C.G. 2003: Philosophy of treatment and the role of chemotherapy in paediatric soft tissue sarcomas. EJC Suppls 1(6): 237-247
Senter, P. 2000: Philothamnus heterodermus Defense. Herpetological Review 31(3): 179
Lilas, L.A.; Mumtaz, F.H.; Madders, D.J.; McNicholas, T.A. 1999: Phimosis after penile Mondor's phlebitis. Bju International 83(4): 520-521
Buyukalpelli, R.; Sarikaya, S.; Asci, R. 1999: Phimosis and circumcision in children. European Urology 35(1)
Ito, K. 2000: Phimosis curing appliance. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Valente, M. 2003: Phitoestrogens efficacy on bone loss risk. Calcified Tissue International 72(4): 381-382
Doi, K.; Wanibuchi, H.; Wei, M.; Morimura, K.; Mitsuhashi, M.; Hoshi, M.; Shen, J.; Fukushima, S. 2003: PhlP, a genotoxic carcinogen, has a practical threshold; evidence in AOM-PhlP-induced rat colon carcinogenesis. Proceedings of the American Association for Cancer Research 44: 286-287
Lundell, T.; Hilden, K.; Hatakka, A.; Martinez, A.T. 2003: Phlebia radiata MnP and LiP enzymes Phylogenetic diversity and a new cluster within the fungal ligninolytic peroxidases. FEMS Congress of European Microbiologists Abstract Book 1: 85
Farias, E.; Gonzalez, E.; Estrada, S. 2001: Phlebitis related to chemotherapy in oncological patients. European Journal of Cancer 37(Suppl 6): S416
Deschamps, J.; Moreno, G. 1999: Phlebopus bruchii An edible fungus from Argentina with possible commercial value. Mycotaxon 72: 205-213
Ibanez Bernal, Sergio 2002: Phlebotominae of Mexico III The species of Lutzomyia Barretto, of the Aragoi group, of L Barretto, of the Dreisbachi group, and of L Barretto. Folia Entomologica Mexicana 41(2): 149-183
Ibanez Bernal, Sergio 2003: Phlebotominae of Mexico IV Species of Lutzomyia Mangabeira, L Barretto, Lutzomyia grupo Oswaldoi, L Barretto and ungrouped species of the genus. Folia Entomologica Mexicana 42(2): 109-152
Marcondes, C.B.; Conceicao, M.B.E.; Portes, M.G.T.; Simao, B.P. 2000: Phlebotomine fauna in a focus of dermal leishmaniasis in the eastern region of Santa Catarina State, southern Brazil Preliminary observations. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 328
Cardenas, R.; Gutierrez, M.; Angulo, V.M.; Munstermann, L.E.; Sandoval, M.; Ferro, C. 2000: Phlebotomine sand flies associated with transmission of urban cutaneous leishmaniasis in northwestern Colombia. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 377-378
Svobodova, M.; Sadlova, J.; Votypka, J.; Volf, P.; Chang, K.P. 2000: Phlebotomine sandflies and rodents in endemic focus of Leishmania tropica in Urfa, Turkey. Journal of Eukaryotic Microbiology 47(2): 8A, March-April
Niang, A.A.; Ba, Y.; Trouillet, J.; Fontenille, D. 2002: Phlebotomine sandflies of Senegal First description of the male of Sergentomyia herollandi Abonnenc, 1960, and redescription of the female. Bulletin de la Societe Entomologique de France 107(4): 429-433
Barral, A. 1999: Phlebotomines and Leishmania Molecular epidemiological, approaches for understanding leishmaniasis transmission. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 19
Svobodova, M.; Votypka, J.; Peckova, J.; Jacobson, R.L.; Warburg, A. 2004: Phlebotomus arabicus - a new vector of Leishmania tropica. Journal of Eukaryotic Microbiology 51(2): 20A
Picado,A.; Das,M.L.; VijayKumar; Dinesh,D.S.; SumanRijal; Singh,S.P.; PredeepDas; Coosemans,M.; Boelaert,M.; Davies,C. 2010: Phlebotomus argentipes seasonal patterns in India and Nepal. Journal Of Medical Entomology: 2, 283-286
Casinelli, K.; Nobili, C.; Limodio, M.; Anzalone, E.; Fabrizi, P.; Falco, M.C.; Petrucci, A.; Sarracino, L.; Savo, M.; Gallo, A.; Ceccarelli, A. 1999: Phlebotomy efficacy before interferon therapy in a case of chronic C hepatitis and hemocromatosis. Journal of Hepatology 30(Suppl 1): 266
Fernandez Real, J.M.; Penarroja, G.; Castro, A.; Lainez, B.; Viejo, A.L.; Garcia Bragado, F.; Ricart, W. 2000: Phlebotomy improves vascular dysfunction in type 2 diabetes mellitus. Diabetologia 43(Suppl 1): A54
Desai, T.K. 2000: Phlebotomy reduces transaminase levels in patients with non-alcoholic steatohepatitis. Gastroenterology 118(4 Suppl 2 Pt 1): AASLD A975
Conry-Cantilena, C. 2001: Phlebotomy, blood donation, and hereditary hemochromatosis. Transfusion Medicine Reviews 15(2): 136-143
Gaulke, R. 2003: Phlegmon of the forearm due to therapy with Anakinra. Zeitschrift fuer Rheumatologie 62(6): 566-569
Bobrov, V.M.; Lysenko, V.A. 2003: Phlegmon of the neck. Vestnik Otorinolaringologii 5: 61-62
Dorosh, A.; Hasek, J.; Janatova, I. 2003: Phleomycin and zeocin as selective agents in transformation of Schwanniomyces occidentalis. FEMS Congress of European Microbiologists Abstract Book 1: 466
Durand, M.F.; Connellan, S.J.; Nagendran, V.; Nelson, P.N.; Perera, S. 1999: Phleum pratense pollen specific immunoglobulin A detection in the saliva of 35 adults by a novel indirect ELISA. Immunology 98(Suppl 1): 140
Van Neerven, R.J.J.; Wissenbach, M.; Arnved, J.; Ipsen, H. 1999: Phleum pratense-specific T-cells of allergic rhinitis patients display a broader recognition pattern than Phleum pratense-specific serum IgE. Journal of Allergy and Clinical Immunology 103(1 Part 2): S108
Botha, C.E.J. 2003: Phloem loading in grasses An apoplasmic main event with a slow symplasmic sideshow. South African Journal of Botany 69(2): 226
Lemoine, R. 2002: Phloem structure and functions in higher plants. Comptes Rendus de l'Academie d'Agriculture de France 88(8): 57-62
Klingler, J.; Thompson, G.A.; Perl Treves, R. 1999: Phloem-specific aphid resistance in melon. Plant Biology (Rockville) : 17
Liu, Q.; Zhao, Y.; Davis, R.E. 2003: Phloem-specific expression of the beta-glucuronidase reporter gene in transgenic strawberry. In Vitro Cellular and Developmental Biology. Plant 39: 43A
Uchiyama, M.; Kim, S.H.; Akaike, T. 2001: Phloretin induced apoptosis in primary cultured hepatocetes. Cell Structure and Function 26(5): 459
Miller, J.S.; Manalis, R.S. 2003: Phloretin inhibits membrane water transport in avian erythrocytes. FASEB Journal 17(4-5): Abstract 591
Stewart, G.S.; Fenton, R.A.; Thevenod, F.; Smith, C.P. 2002: Phloretin-inhibitable urea transport in the mouse colon. Journal of Physiology (Cambridge) 544P: 94P
Bush, Eugene N.; Shapiro, D. Robin; Adler, Andrew L.; Kramer, Deborah L.; Wu Wong, Jinshyun R.; Jacobson, Peer; Opgenorth, Terry J. 1999: Phlorizin treatment of Zucker Diabetic Fatty rats for one week decreased blood glucose and triglycerides without significant alterations of urine volume, glucosuria, renal function, or insulin resistance. Diabetes 48(Suppl 1): A281
Hwu, J.R.; Tsay, S.C.; Hakimelahi, G.H.; Lin, C.C.; Tseng, W.N.; Moshfegh, A.A.; Azaripour, A.; Mottaghian, H. 2000: Phloroglucide derivatives and their pharmceutical use. Official Gazette of the United States Patent and Trademark Office Patents 1238(3)
Hwu, J.R.; Tsay, S.C.; Hakimelahi, G.H.; Lin, C.C.; Tseng, W.N.; Moshfegh, A.A.; Azaripour, A.; Mottaghian, H. 2001: Phloroglucidic acid and derivatives as antibacterial agents. Official Gazette of the United States Patent and Trademark Office Patents 1250(2)
Brock, E.; Aberg, P.; Pavia, H. 2001: Phlorotannins as chemical defense against macroalgal epiphytes on Ascophyllum nodosum. Journal of Phycology 37(3 Suppl): 8
Nishizawa, M.; Toh, E.; Akio 2003: Pho85 kinase is involved in the diauxic shift of the yeast Saccharomyces cerevisiae. Yeast 20(Suppl 1): S266
Black, M.T.; Hodgson, J.E.; Knowles, D.J. Charles; Reichard, R.W.; Nicholas, R.O.; Burnham, M.K. Russel; Pratt, J.M.; Rosenberg, M.; Ward, J.M.; Lonetto, M.A.; Warren, P.V. 2001: PhoH homolog. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)
Villa Ramirez, Bernardo 2002: Phocoena sinus Norris and McFarland, 1958. TIP Revista Especializada en Ciencias Quimico-Biologicas 5(1): 20-28
Foster, G.; Ross, H.M.; Malnick, H.; Willems, A.; Hutson, R.A.; Reid, R.J.; Collins, M.D. 2000: Phocoenobacter uteri gen nov, sp nov, a new member of the family Pasteurellaceae Pohl 1981 isolated from a harbour porpoise. International Journal of Systematic and Evolutionary Microbiology 50(6 part 1): 135-139
Yildirim, E. 2002: Phoenicocoris obscurellus a new record and a new scotch pine pest for Turkey from Erzurum. Turkiye Entomoloji Dergisi 26(1): 45-49
Masuoka, Y.; Shin-Ya, K.; Furihata, K.; Nagai, K.; Suzuki, K.; Hayakawa, Y.; Seto, H. 2001: Phoenistatin, a new gene expression-enhancing substance produced by Acremonium fusigerum. Journal of Antibiotics 54(2): 187-190
Riegl, B. 2002: Phoenix from the ashes? Repetitive mass mortality and the biogeology of southern Arabian Gulf coral systems. Bright, Monika , Reprint Author, Dworschak, Peter C, Stachowitsch, Michael , Reprint Author The Vienna School of Marine Biology: A tribute to Joerg Ott: 137-159
Shochat, E.; Katti, M. 2001: Phoenix or Tucson Does landscape structure influence where Aberts Towhees choose to live?. Ecological Society of America Annual Meeting Abstracts 86: 343
Hutton, J.C.; Wasmeier, C.; Bright, N.; Kelemen, K.; Zahn, T.; Bergman, B. 2001: Phogrin A dense core granule membrane protein of neuroendocrine tissues. Regulatory Peptides 97(1): 25, 2 February
Wasmeier, C.; Hutton, J.C. 1999: Phogrin, an insulin granule membrane PTP homologue, is phosphorylated during stimulated insulin release. Diabetologia 42(Suppl 1): A135
Zalacain, M.; Brown, J.R. 1999: Phoh. Official Gazette of the United States Patent and Trademark Office Patents 1220(4): 3509
Reichl, S.; Arnhold, J.; Benard, S.; Arnold, K. 1999: Pholasin chemiluminescence as a tool for detecting reactive oxygen species and myeloperoxidase in neutrophils. European Journal of Clinical Investigation 29(Suppl 1): 52
Cortez, V.G.; Coelho, G. 2003: Pholiota spumosa singer First record from Rio Grande do Sul, Brazil. Biociencias (Porto Alegre) 11(2): 133-136
Koike, S.T.; Subbarao, K.V.; Verkley, G.J.M.; O'neill, T.; Fogle, D. 2003: Phoma basal rot of lettuce caused by P exigua in California. Phytopathology 93(6 Suppl): S47
White, James, F.Jr 2003: Phoma glomerata ATCC MYA-2373 for biocontrol of fungal diseases in plants. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)
Padgett, G.B. 2000: Phomopsis boll dangle epidemics in two cotton cultivars. Phytopathology 90(6 Suppl): S58
Catlin, N.J.; Caruso, F.L. 2002: Phomopsis vaccinii as a probable causal agent of upright dieback of cranberry. Phytopathology 92(6 Suppl): S12
Zowtiak, J.; Young, T.; Wondka, T. 2002: Phonation valve for breathing tube. Official Gazette of the United States Patent and Trademark Office Patents 1254(1)
Deforche, B.; De Bourdeaudhuij, I.; Tanghe, A.; Hills, A.P.; Bouckaert, J. 2002: Phone contact as a follow-up strategy in the treatment of obese children. International Journal of Obesity 26(Suppl 1): S11
Elasy, T.A.; Spickard, A.; Pichert, J.; Swiggart, W.; Dixon, G. 1999: Phone requests for medication refill in a teaching practice. JGIM 14(Suppl 2): 95
Lipton, R.B.; Katz, M.; Kuslansky, G.; Buschke, H.; Verghese, J. 2002: Phone-based screening for dementia in the general population Results from the Einstein Aging Study. Neurology 58(7 Suppl 3): A100
Costa, S.K.P.; Antunes, E.; De Nucci, G.; Brain, S.D.; Docherty, R.J. 2001: Phoneutria nigriventer spider venom activates Na+ channels in the rat vagus nerve in vitro. Journal of Physiology (Cambridge) 531P: 221P-222P
Chanques, G.; Jaber, S.; Delay, J.M.; Perrigault, P.F.; Lefrant, J.Y.; Eledjam, J.J. 2003: Phoning study about postoperative practice and application of non-invasive ventilation. Annales Francaises D'anesthesie et de Reanimation 22(10): 879-885
Martin, R.; Preiksaitis, H.; Lloyd, D.A. 2000: Phonoenterography for evaluation of small bowel motor motility. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1188
Vliet, E.Caccappolo-van.; Miozzo, M.; Stern, Y. 2004: Phonological dyslexia without phonological impairment?. Cognitive Neuropsychology 21(8): 820-839
Hughes, J.D.; Heilman, K.M. 1999: Phonological interference in conduction aphasia. Neurology 52(6 Suppl 2): A489
Hemmerling, T.M.; Donati, F.; Beaulieu, P.; Babin, D. 2002: Phonomyography Is the duration of control stimulation important?. Anesthesia and Analgesia 94(2S Suppl): S 139
Gavriely, N. 2001: Phonopneumograph system. Official Gazette of the United States Patent and Trademark Office Patents 1248(3)
Macklem, P.T.; Que, C.L.; Kelly, S.M.; Kolmaga, K.; Durand, L.G.lles 2001: Phonospirometry for non-invasive monitoring of respiration. Official Gazette of the United States Patent and Trademark Office Patents 1247(1)
Lakes Harlan, R.; Stoelting, H.; Moore, T.E. 2000: Phonotactic behaviour of a parasitoid fly in response to the calling song of its host Cicada. Zoology (Jena) 103(1-2): 31-39
Mason, A.C.; Hoy, R.R. 2001: Phonotaxis in the acoustic parasitoid fly Ormia ochracea. Advances in Ethology 36: 213
Hebert, I.; Khaimskiy, Y.; Athar, M.; Kopelovich, L.; Bickers, D.; Epstein, E. 2004: Phorbol 12-myristate 13-acetate inhibits the induction of basal cell carcinomasin Ptch1+/- mice. Journal of Investigative Dermatology 122(3): A28
Rahmani, M.; Grant, S. 2002: Phorbol 12-myristate 13-acetate interacts synergistically with the checkpoint abrogator 7-hydroxystaurosporine to induce mitochondrial damage and apoptosis in U937 human myeloid leukemia cells. Proceedings of the American Association for Cancer Research 43: 66
Wang, X.F.; Wang, Q.D.; Hu, W.Q.; Thomas, R.P.; Evers, B.M. 2002: Phorbol 12-myristate 13-acetate upregulates expression of proapoptotic genes and increases the sensitivity of Panc-1 cells to TRAIL. Gastroenterology 122(4 Suppl 1): A-242
Uno, T.; Kawahara, J.; Tanako, A.; Iwata, M.; Haruta, T. 2001: Phorbol 12-myristate 13-acetate-induced insulin resistance is mediated by a mammalian target of rapamycin pathway. Diabetes 50(Suppl 2): A288
Hussaini, I.M.; Karns, L.R.; Vinton, G.; Carpenter, J.; Redpath, G.T.; Sando, J.J.; Vandenberg, S.R. 1999: Phorbol 12-myristate-13-acetate induces protein kinase C-eta-specific cell proliferative response in astrocytic tumor cells. Society for Neuroscience Abstracts 25(1-2): 1798
Hattori, M. 2001: Phorbol derivatives having antivirus activity. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)
Mazer, B.; Zhuang, Q.L.; Bastein, Y.; Zhang, J.H. 1999: Phorbol ester and calcium ionophore downregulates platelet-activating factor receptor expression in a B lymphoid cell line. Journal of Allergy and Clinical Immunology 103(1 Part 2): S241
Chen, C.S.; Chen, W.N. U. 2000: Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. Molecular Biology of the Cell 11(Suppl): 524a
Yuziuk, J.A.; Daniel, L.W. 2000: Phorbol ester induces prostaglandin endoperoxide H synthase-2 expression via A p38 map kinase-dependent pathway in a human colorectal adenocarcinoma cell line. Proceedings of the American Association for Cancer Research 41: 63
Biro, T.; Boczan, J.; Papp, H.; Kovacs, L. 2000: Phorbol ester treatment inhibits proliferation and differentiation of cultured human skeletal muscle cells by differentially acting on protein kinase C isoforms. Journal of Physiology (Cambridge) 526P: 32P-33P
Hamamoto, Y.; Nagai, K.; Ogasawara, Y.; Inoue, K.; Ichimiya, M.; Muto, M. 2001: Phorbol ester-induced apoptosis associated with syncytia formation in human monocytic cell lines established from peripheral blood of patients with atopic dermatitis and psoriasis. Journal of Investigative Dermatology 117(2): 463
Powell, C.Thomas 1999: Phorbol ester-induced apoptosis of human prostate cancer cells involves prolonged activation of the MAP kinase pathway and correlates with expression of RasGRP mRNA. Proceedings of the American Association for Cancer Research 40: 580
Wang, Q.; Wang, X.; Thomas, R.P.; Walker, S.L.; Hellmich, M.R.; Evers, B.M.rk 2002: Phorbol ester-induced cIAP2 expression in human colon cancer cells is dependent on the novel protein kinase C-delta. Proceedings of the American Association for Cancer Research 43: 530
Heldt, C.; Hass, R. 1999: Phorbol ester-induced differentiation of human myeloid leukemia cells is inhibited by antisense CD11b integrin expression. European Journal of Cell Biology 78(Suppl 49): 38
Schwager, S.L.U.; Chubb, A.J.; Scholle, R.R.; Naidoo, K.; Brandt, W.F.; Eckerskorn, C.; Sturrock, E.D.; Ehlers, M.R.W. 1999: Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a disulfide-bridged stalk. Biochemical Society Transactions 27(1): A56
Loos, J.C.; Garzotto, M. 2003: Phorbol ester-mediated apoptosis in LNCaP cells is P53-independent. Journal of Urology 169(4 Suppl): 219
Wang, X.; Wang, Q.; Evers, B.M.rk 2001: Phorbol ester-mediated neurotensin gene induction is regulated by a Ras/PKC/ATF-2 dependent pathway. Gastroenterology 120(5 Suppl 1): A 309
Bobrovskaya, L.; Cheah, T.B.; Dunkley, P.R. 1999: Phorbol ester-mediated phosphorylation of tyrosine hydroxylase in bovine adrenal chromaffin cells. Journal of Neurochemistry 72(Suppl ): S25
Chang, P.L.; Chambers, A.F.; Prince, C.W. 1999: Phorbol ester-treated mouse epidermal cells bind to osteopontin through alphav-containing integrin. Proceedings of the American Association for Cancer Research 40: 462
Chang, R.L.; Han, Z.T.o 2000: Phorbol esters as anti-neoplastic and white blood cell elevating agents. Official Gazette of the United States Patent and Trademark Office Patents 1234(3)
Jones, K.S.; Ruscetti, F.W.; Sadowski, C.; Nath, M. 2001: Phorbol esters down modulate expression of cell surface protein critical for direct binding of an HTLV-1 SU fusion protein. AIDS Research and Human Retroviruses 17(Suppl 1): S 22
Nie, Z.; Mei, Y.; Ramkumar, V. 1999: Phorbol esters increase A1 adenosine receptor expression by activation of AP-1 and NFkappaB transcription factors. FASEB Journal 13(4 Part 1): A462
Jin, S.; Schatter, B.; Koetter, K.; Weichel, O.; Park, J.B.; Ryu, S.H.; Klein, J. 2000: Phorbol esters increase activity and gene expression of phospholipase D in astrocytes. Chemistry and Physics of Lipids 107(1): 38
Fultz, M.E.; Li, C.; Wright, G.L. 2001: Phorbol induced remodeling of the actin cytoskeleton in the contracting A7R5 smooth muscle cell. FASEB Journal 15(5): A1126
Kikuchi, M.; Tachimoto, H.; Hudson, S.A.; Bochner, B.S. 2000: Phorbol myristate acetate alters human eosinophil expression of alpha4beta1 and alphadbeta2 integrins and adhesion to VCAM-1 under static and flow. Journal of Allergy and Clinical Immunology 105(1 part 2): S258
Pedron, T.; Girard, R.; Chaby, R. 2000: Phorbol myristate acetate blocks LPS-induced expression of membrane CD14 in mouse bone marrow granulocytes Involvement of PKC-alpha. Journal of Endotoxin Research 6(2): 133
Kharazi, A.I.; Kudinov, Y.G.; Escobar, A.I.; Wiseman, C.L. 2000: Phorbol myristate acetate can potentiate gamma-interferon-induced up-regulation of MHC Class II antigens in tumor cell lines. Journal of Immunotherapy 23(5): 589
Kiningham, Kelley; Xu, Yong; Daosukho, Chotiros; Popova, Bilyana; St Clair, Daret K. 1999: Phorbol-12-myristate 13-acetate enhances cytokine inducibility of the SOD2 gene. Free Radical Biology and Medicine 27(Suppl 1): S62
Lahad, I.; Katz, R.; Pollack, S. 2000: Phorbol-ester stimulated MAPK activity in human monocytic cell lines is partially PKC-dependent and is related to the monocytic maturation state. FASEB Journal 14(6): A1063
Li, C.; Fultz, M.E.; Geng, W.; Wright, G.L. 2000: Phorbol-induced PKCalpha translocation to different subcellular sites is concentration-dependent and requires an intact cytoskeleton in A7r5 cells. FASEB Journal 14(4): A417
Kato, A.; Fukazawa, Y.; Fujitani, K.; Inokuchi, K.; Sugiyama, H. 1999: Phorbolester promotes synaptic distribution of Vesl-1S/Homer-1a protein which is upregulated during long-term potentiation. Society for Neuroscience Abstracts 25(1-2): 466